{"gene":"HTR1A","run_date":"2026-04-28T18:06:53","timeline":{"discoveries":[{"year":1987,"finding":"The HTR1A gene is an intronless gene encoding a G-protein-coupled receptor with structural homology to adrenergic receptors, identified by cross-hybridization with a beta-2 adrenergic receptor probe.","method":"Molecular cloning and DNA sequencing","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 — original cloning and sequencing of the gene, foundational paper with >400 citations","pmids":["3041227"],"is_preprint":false},{"year":1988,"finding":"The protein product of genomic clone G-21 (HTR1A) transiently expressed in monkey kidney cells displays all typical ligand-binding characteristics of the 5-HT1A receptor, establishing the identity of the cloned gene.","method":"Transient expression in COS-7 cells with radioligand binding assays","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 — direct functional reconstitution of cloned receptor in mammalian cells, >500 citations","pmids":["3138543"],"is_preprint":false},{"year":1989,"finding":"The cloned human 5-HT1A receptor couples to multiple signal transduction pathways via pertussis toxin-sensitive G-proteins: it inhibits adenylyl cyclase (EC50 ~20 nM for 5-HT) and, at higher agonist concentrations, stimulates phospholipase C. No stimulation of adenylyl cyclase was observed.","method":"Transient (COS-7) and stable (HeLa) expression, cAMP and inositol phosphate assays, pertussis toxin treatment","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstituted receptor signaling in two cell lines with multiple orthogonal functional assays and pharmacological controls; >270 citations","pmids":["2549039"],"is_preprint":false},{"year":1993,"finding":"Human 5-HT1A receptors physically and functionally couple to multiple Gi alpha subunits (Gi-alpha1, Gi-alpha2, Gi-alpha3) in a cell-type-dependent manner: Gi-alpha3 predominates in HeLa cells while Gi-alpha2 predominates in CHO-K1 cells. No physical or functional coupling to Gs alpha was detected. Agonist promotes receptor–G protein co-immunoprecipitation.","method":"Co-immunoprecipitation, high-affinity agonist binding, adenylyl cyclase inhibition assays with Gi-subtype-specific antisera in two cell lines","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1-2 — reciprocal co-immunoprecipitation and functional reconstitution with multiple G-protein subunit antisera in two independent cell systems","pmids":["8218170"],"is_preprint":false},{"year":1996,"finding":"The 5-HT1A receptor gene contains a TATA-less, GC-rich promoter. Transcription factors MAZ (Pur-1/Zif87) and Sp1 bind to GC-rich elements in the promoter; overexpression of MAZ or Sp1 increases reporter expression, with MAZ being substantially more effective. An initiator-like element was also identified.","method":"RNA 5'-end mapping, DNase I footprinting, transient transfection reporter assays, cDNA cloning of MAZ","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods (footprinting, cDNA cloning, functional overexpression assays) in a single rigorous study","pmids":["8626793"],"is_preprint":false},{"year":2000,"finding":"Methiothepin and spiperone act as inverse agonists at the 5-HT1A receptor, inhibiting both agonist-stimulated and basal [35S]GTPgammaS binding. Simulations using the extended ternary complex model indicate spiperone stabilizes receptor forms uncoupled from G proteins, while methiothepin may stabilize an inactive receptor form that retains G-protein coupling.","method":"[35S]GTPgammaS binding assay in CHO cells expressing human 5-HT1A receptor, GDP/sodium titration, extended ternary complex modeling","journal":"Journal of neurochemistry","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro functional assay with mechanistic modeling and systematic pharmacological dissection","pmids":["10617139"],"is_preprint":false},{"year":2002,"finding":"Aripiprazole binds with high affinity to recombinant human 5-HT1A receptors and acts as a potent partial agonist, as demonstrated by stimulation of [35S]GTPgammaS binding that is fully blocked by a selective 5-HT1A antagonist.","method":"Radioligand binding and [35S]GTPgammaS functional assay in CHO cell membranes expressing human 5-HT1A receptor","journal":"European journal of pharmacology","confidence":"High","confidence_rationale":"Tier 2 — receptor binding plus functional G-protein activation assay with selective antagonist control","pmids":["12063084"],"is_preprint":false},{"year":2003,"finding":"The C(-1019)G polymorphism in the HTR1A promoter is associated with major depression and suicide. The C(-1019) allele forms a 26 bp palindrome that binds transcription factors NUDR/DEAF-1 and Hes5 to repress the 5-HT1A promoter; the G(-1019) allele abolishes NUDR-mediated repression. Stable NUDR expression in raphe cells reduced endogenous 5-HT1A protein and binding. NUDR co-localizes with 5-HT1A receptors in raphe cells and hippocampal/cortical neurons.","method":"EMSA, co-immunoprecipitation, stable cell line expression, radioligand binding, immunohistochemistry, case-control genetic association","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods establishing transcriptional mechanism in cell culture and in vivo; >500 citations","pmids":["14507979"],"is_preprint":false},{"year":2005,"finding":"Activation of 5-HT1A receptors in PFC pyramidal neurons inhibits NR2B subunit-containing NMDA receptor-mediated currents via a microtubule-dependent mechanism. The effect requires intact microtubule assembly, the kinesin motor KIF17 (which transports NR2B vesicles along dendrites), and CaMKII and MEK/ERK signaling. 5-HT1A activation reduces microtubule stability and decreases surface NR2B subunit density on dendrites.","method":"Whole-cell patch-clamp recordings in PFC slices, pharmacological inhibitors, siRNA knockdown of KIF17, immunocytochemistry, biochemical microtubule stability assay","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods (electrophysiology, RNAi, biochemistry, imaging) in a single study defining a complete mechanistic pathway","pmids":["15944377"],"is_preprint":false},{"year":2005,"finding":"Cannabidiol (CBD) displaces [3H]8-OH-DPAT from the cloned human 5-HT1A receptor in a concentration-dependent manner and acts as a modest-affinity agonist, increasing [35S]GTPgammaS binding and decreasing cAMP levels similarly to serotonin.","method":"Radioligand displacement binding assay and [35S]GTPgammaS binding/cAMP assay in cells expressing human 5-HT1A receptor","journal":"Neurochemical research","confidence":"Medium","confidence_rationale":"Tier 2 — two independent functional assays in cell culture; single lab","pmids":["16258853"],"is_preprint":false},{"year":2006,"finding":"Native rat hippocampal 5-HT1A receptors exhibit constitutive G-protein (Galpha-o) activity in vitro; spiperone and methiothepin act as inverse agonists by reducing basal [35S]GTPgammaS binding to Galpha-o, and these effects are antagonized by WAY100,635 with affinities consistent with the 5-HT1A receptor.","method":"Anti-Galpha-o antibody capture coupled to scintillation proximity assay for [35S]GTPgammaS binding in native rat hippocampal membranes","journal":"Molecular pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 — native receptor preparation with selective pharmacological controls; single lab","pmids":["17167032"],"is_preprint":false},{"year":2008,"finding":"The C-terminal 17 aa domain of the 5-HT1A receptor interacts with Yif1B (a mammalian homologue of yeast Yif1p involved in ER-to-Golgi vesicular trafficking). This interaction was confirmed by GST pulldown from rat brain extracts and transfected cells. siRNA knockdown of Yif1B in primary neurons specifically prevented targeting of 5-HT1A receptor to distal dendrites without affecting other receptors.","method":"Yeast two-hybrid screen, GST pulldown, siRNA knockdown in primary neurons, immunofluorescence co-localization","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — yeast two-hybrid confirmed by GST pulldown from native tissue plus RNAi functional validation in primary neurons","pmids":["18685031"],"is_preprint":false},{"year":2008,"finding":"The 5-HT1A receptor forms homo-oligomers (predominantly dimers) at the plasma membrane of neuroblastoma cells. Agonist stimulation decreases apparent FRET efficiency between CFP/YFP-labeled receptor pairs, suggesting conformational rearrangement of oligomers rather than dissociation. Palmitoylation of the receptor is required for this agonist-induced conformational change, as acylation-deficient mutants fail to show the agonist-mediated FRET decrease.","method":"FRET (acceptor photobleaching, fluorescence lifetime, spectral analysis) in living N1E-115 cells; biochemical analysis with palmitoylation-deficient mutants","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 2 — multiple FRET approaches in living cells with mutagenesis; single lab","pmids":["18381076"],"is_preprint":false},{"year":2010,"finding":"Genetic disruption of RGS protein regulation at Galpha-i2 (G184S knock-in mice) selectively potentiates 5-HT1A receptor-mediated antidepressant-like and anxiolytic-like behaviors, and increases cortical/hippocampal GSK-3beta phosphorylation. Both behavioral and biochemical phenotypes are blocked by the 5-HT1A-selective antagonist WAY 100635, placing RGS-Galpha-i2 as a key negative regulator downstream of 5-HT1A receptor signaling.","method":"RGS-insensitive Galpha-i2 knock-in mice, behavioral tests, pharmacological blockade with WAY 100635, biochemical phosphorylation assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis in knock-in mice with pharmacological rescue and biochemical endpoint; multiple orthogonal methods","pmids":["20534514"],"is_preprint":false},{"year":2010,"finding":"Selective manipulation of 5-HT1A autoreceptor levels in raphe nuclei (without affecting postsynaptic heteroreceptors) causally determines raphe 5-HT neuron firing rates, stress resilience, and antidepressant response. 1A-High mice show blunted stress response and no antidepressant behavioral response; reducing autoreceptor levels prior to treatment converts non-responders to responders.","method":"Conditional transgenic mice with region-specific autoreceptor level manipulation, electrophysiology, behavioral tests, antidepressant treatment paradigm","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 — genetic causal manipulation with electrophysiological and behavioral readouts; strong preponderance of evidence","pmids":["20152112"],"is_preprint":false},{"year":2004,"finding":"Serotonin, acting via 5-HT1A receptors, hyperpolarizes orexin/hypocretin neurons through activation of GIRK channels (single-channel conductance ~33.8 pS). 5-HT1A receptor immunoreactivity was identified on orexin neurons, and WAY100635 blocked the hyperpolarization. Blockade of 5-HT1A receptors in orexin-neuron-intact (but not ablated) mice increased locomotor activity, indicating this pathway tonically inhibits orexin neuron activity.","method":"Patch-clamp recordings (whole-cell and single-channel) in hypothalamic slices from orexin-EGFP mice, pharmacology, immunohistochemistry, icv injection with orexin-ablated mouse comparison","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1-2 — direct electrophysiology with single-channel biophysics, immunohistochemistry, and in vivo pharmacogenetic validation","pmids":["15306649"],"is_preprint":false},{"year":2004,"finding":"5-HT2A receptor activation in the hypothalamic paraventricular nucleus induces heterologous desensitization of co-expressed 5-HT1A receptors, as demonstrated by reduced oxytocin and ACTH responses to 5-HT1A agonist. Intra-PVN microinjection of a 5-HT2A antagonist dose-dependently prevented this desensitization. Double-label immunocytochemistry confirmed co-localization of 5-HT1A and 5-HT2A receptors in individual PVN neuroendocrine cells.","method":"In vivo neuroendocrine hormone assays, intra-PVN microinjections, double-label immunocytochemistry","journal":"The Journal of pharmacology and experimental therapeutics","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo pharmacological interaction with microinjection controls and immunocytochemical colocalization; single lab","pmids":["15064330"],"is_preprint":false},{"year":2019,"finding":"miR-26a-2 directly downregulates Htr1a expression in serotonergic neurons (confirmed by reporter assays with the Htr1a 5'UTR). In vivo, miR-26a-2 overexpression in serotonergic neurons improves stress resilience and antidepressant response, effects abrogated by Htr1a overexpression; miR-26a-2 knockdown increases anxiety and impairs antidepressant response, rescued by Htr1a silencing.","method":"Luciferase reporter assays, transgenic mouse models with serotonergic-neuron-specific miR-26a-2 overexpression or knockdown, behavioral tests, lentiviral Htr1a manipulation","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 — reporter assay for direct targeting plus reciprocal gain/loss-of-function in vivo with genetic rescue","pmids":["30808545"],"is_preprint":false},{"year":2021,"finding":"HTR1A antagonism (WAY-100635) upregulates GnRH expression in GT1-7 neurons via an epigenetic mechanism: it reduces CBX4 expression, causing degradation of Polycomb Repressive Complex 1 (PRC1) and loss of H2AK119 ubiquitination at the GnRH promoter. CBX4 downregulation is mediated by suppression of PI3K/Akt and MAPK/ERK pathways.","method":"RNA-seq, ChIP-seq for CBX4 and H2AK119ub, co-immunoprecipitation, pharmacological inhibitor studies in GT1-7 cells","journal":"Molecular therapy. Nucleic acids","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal genomic and biochemical approaches; single lab, cell line model","pmids":["34458005"],"is_preprint":false},{"year":2021,"finding":"Cryo-EM structures of 5-HT1A receptor in complex with Gi protein were determined in apo state, bound to 5-HT, and bound to aripiprazole. Phosphatidylinositol 4-phosphate (PI4P) is present at the G-protein–5-HT1A interface and increases 5-HT1A-mediated G-protein activity. Cholesterol molecules directly shape the ligand-binding pocket and determine specificity for aripiprazole. Structured water molecules in the apo-receptor binding pocket mimic 5-HT to maintain basal activation.","method":"Cryo-EM structure determination, lipid biochemistry (PI4P functional assay), G-protein activation assay","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 — cryo-EM structures with functional validation of lipid regulation; multiple structures with mechanistic insight","pmids":["33762731"],"is_preprint":false},{"year":2016,"finding":"Molecular dynamics simulations of the 5-HT1A receptor with two epimers of dihydrofuroaporphine (agonist vs. antagonist) revealed that the agonist mobilizes nearby amino acid residues as molecular switches to form a continuous water channel, whereas the antagonist epimer remains firmly stabilized in the binding pocket without triggering this conformational change.","method":"All-atom long-timescale molecular dynamics simulations with molecular interaction fingerprint analysis","journal":"Angewandte Chemie (International ed. in English)","confidence":"Low","confidence_rationale":"Tier 4 — computational prediction only, no experimental mutagenesis validation","pmids":["27244650"],"is_preprint":false},{"year":2022,"finding":"HTR1A interacts with TRIM21 and PSMD7 (components of the ubiquitin-proteasome pathway) to inhibit TβRII degradation, thereby suppressing TGF-β canonical and non-canonical signaling in triple-negative breast cancer cells. This was demonstrated by co-immunoprecipitation and RNA-seq analysis.","method":"Co-immunoprecipitation, siRNA screening, RNA-seq, in vivo xenograft experiments","journal":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","confidence":"Medium","confidence_rationale":"Tier 2-3 — co-immunoprecipitation plus in vivo functional experiments; single lab","pmids":["35199941"],"is_preprint":false},{"year":2012,"finding":"A subpopulation (~16%) of serotonergic neurons in the dorsal, lateral, and median raphe does not express the somatodendritic 5-HT1A autoreceptor mRNA. These 5-HT1A-negative neurons fire more action potentials upon large depolarizing current injection than 5-HT1A-positive neurons, consistent with lack of autoinhibitory feedback from locally released 5-HT.","method":"Histochemistry in ePet1-eGFP and 5-HT1A-iCre/R26R mice, patch-clamp recording followed by single-cell PCR","journal":"ACS chemical neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — electrophysiology combined with single-cell PCR genotyping in identified neurons; single lab","pmids":["23336048"],"is_preprint":false},{"year":2002,"finding":"Genetic deletion of the 5-HT1A autoreceptor in knockout mice nearly doubles the mean firing rate of dorsal raphe 5-HT neurons. No compensatory changes in 5-HT1B, 5-HT1D, or alpha2-adrenergic autoreceptor function were detected in hippocampus or frontal cortex.","method":"Extracellular electrophysiological recordings in 5-HT1A knockout mice, radioligand release assays in preloaded brain slices","journal":"European journal of pharmacology","confidence":"High","confidence_rationale":"Tier 2 — genetic loss-of-function with electrophysiology and neurochemical assays; clean KO model","pmids":["11821026"],"is_preprint":false},{"year":1995,"finding":"Glucocorticoid hormones negatively regulate transcription of the hippocampal 5-HT1A receptor gene: adrenalectomy increases 5-HT1A mRNA within 1 hour (preceding receptor binding site increases) and elevates transcription rate by 70% in nuclear run-on assays; dexamethasone treatment completely prevents this increase. Adrenalectomy did not alter functional coupling of 5-HT1A receptors to adenylyl cyclase or phospholipase C.","method":"In situ hybridization, RNase protection assays, nuclear run-on transcription assays, adrenalectomy/steroid replacement in rats","journal":"Brain research. Molecular brain research","confidence":"High","confidence_rationale":"Tier 1-2 — nuclear run-on plus mRNA quantification with pharmacological rescue; multiple orthogonal methods","pmids":["7769998"],"is_preprint":false}],"current_model":"HTR1A encodes a Gi/o-coupled GPCR that, upon serotonin binding, inhibits adenylyl cyclase and (at higher occupancy) activates phospholipase C via pertussis toxin-sensitive G proteins; it preferentially couples to Gi-alpha3 in raphe cells and Gi-alpha2 in hippocampal neurons, opening GIRK channels and closing calcium channels to hyperpolarize neurons; its dendritic targeting depends on interaction of its C-terminal domain with the ER/Golgi trafficking protein Yif1B; it forms palmitoylation-dependent homo-oligomers whose conformation changes upon agonist activation; cryo-EM structures reveal that phosphatidylinositol 4-phosphate at the G-protein interface enhances signaling, cholesterol shapes the ligand-binding pocket, and structured water molecules maintain basal activity; as a somatodendritic autoreceptor it provides inhibitory feedback that sets raphe neuron firing rate and serotonin release, and its expression is transcriptionally controlled by glucocorticoids, the MAZ/Sp1 promoter complex, and the NUDR/DEAF-1 repressor at the C(-1019)G polymorphism; RGS proteins acting at Galpha-i2 constrain 5-HT1A-mediated antidepressant signaling, and miR-26a-2 post-transcriptionally suppresses autoreceptor levels to modulate stress resilience."},"narrative":{"teleology":[{"year":1987,"claim":"Cloning of the HTR1A gene revealed an intronless GPCR with adrenergic receptor homology, establishing the molecular identity of the 5-HT1A receptor for the first time.","evidence":"Molecular cloning via cross-hybridization with β2-adrenergic receptor probe, DNA sequencing","pmids":["3041227"],"confidence":"High","gaps":["No functional data confirming receptor activity","Endogenous ligand binding not demonstrated"]},{"year":1988,"claim":"Functional expression of the cloned gene confirmed that it encodes a receptor with the full pharmacological profile of the native 5-HT1A site, validating the clone's identity.","evidence":"Transient expression in COS-7 cells with radioligand binding assays","pmids":["3138543"],"confidence":"High","gaps":["Downstream signaling pathways not yet characterized","G-protein coupling specificity unknown"]},{"year":1989,"claim":"Reconstitution of signaling showed the receptor inhibits adenylyl cyclase and, at higher occupancy, activates phospholipase C—both through pertussis toxin-sensitive G proteins—defining its dual effector coupling.","evidence":"cAMP and inositol phosphate assays in COS-7 and HeLa cells with pertussis toxin treatment","pmids":["2549039"],"confidence":"High","gaps":["Identity of specific Gα subunits unknown","In vivo effector pathway relevance not established"]},{"year":1993,"claim":"Identification of cell-type-dependent coupling to specific Gαi subunits (Gαi2 vs. Gαi3) explained how the same receptor could produce different signaling outputs in different neuronal populations.","evidence":"Co-immunoprecipitation with Gi-subtype-specific antisera and adenylyl cyclase inhibition in HeLa and CHO-K1 cells","pmids":["8218170"],"confidence":"High","gaps":["Native neuronal Gα coupling preferences not determined","Mechanism of cell-type selectivity unclear"]},{"year":1995,"claim":"Demonstrating that glucocorticoids negatively regulate HTR1A transcription at the nuclear run-on level revealed a mechanism by which stress hormones modulate serotonergic tone.","evidence":"Nuclear run-on assays, in situ hybridization, adrenalectomy/dexamethasone replacement in rats","pmids":["7769998"],"confidence":"High","gaps":["Glucocorticoid response element not mapped","Whether regulation is direct or indirect not resolved"]},{"year":1996,"claim":"Characterization of the TATA-less, GC-rich promoter and identification of MAZ and Sp1 as transcriptional activators defined the basal transcriptional machinery for HTR1A expression.","evidence":"DNase I footprinting, reporter assays, MAZ cDNA cloning","pmids":["8626793"],"confidence":"High","gaps":["Cell-type-specific transcriptional regulation not addressed","Relationship to in vivo autoreceptor vs. heteroreceptor expression unknown"]},{"year":2000,"claim":"Demonstration that methiothepin and spiperone act as inverse agonists established that 5-HT1A receptors possess constitutive activity, with distinct mechanisms of inverse agonism (G-protein-uncoupled vs. inactive coupled state).","evidence":"[35S]GTPγS binding in CHO cells with extended ternary complex modeling","pmids":["10617139"],"confidence":"High","gaps":["Constitutive activity not yet confirmed in native tissue at that time","Structural basis of basal activity unknown"]},{"year":2002,"claim":"Genetic deletion of 5-HT1A in knockout mice nearly doubled raphe firing rate without compensatory changes in other autoreceptors, providing causal evidence that the autoreceptor is the principal brake on serotonergic neuron activity.","evidence":"Extracellular recordings in dorsal raphe of 5-HT1A KO mice, radioligand release assays","pmids":["11821026"],"confidence":"High","gaps":["Postsynaptic heteroreceptor contributions confounded in global KO","Developmental compensation cannot be excluded"]},{"year":2003,"claim":"Discovery that the C(-1019)G promoter polymorphism abolishes NUDR/DEAF-1-mediated repression linked a specific transcriptional mechanism to major depression risk, connecting autoreceptor expression levels to psychiatric disease.","evidence":"EMSA, co-IP, stable expression reducing endogenous 5-HT1A, immunohistochemistry, case-control genetic association","pmids":["14507979"],"confidence":"High","gaps":["Causal chain from polymorphism to disease phenotype not fully established","Population-level effect size and replication across cohorts debated"]},{"year":2004,"claim":"Electrophysiological recordings showed that 5-HT1A activation hyperpolarizes orexin neurons via GIRK channels (~33.8 pS), providing a defined ionic mechanism for serotonergic inhibition of arousal circuits.","evidence":"Whole-cell and single-channel patch clamp in hypothalamic slices, pharmacological blockade, in vivo validation with orexin-ablated mice","pmids":["15306649"],"confidence":"High","gaps":["Contribution to sleep-wake regulation in intact circuitry not quantified","Whether GIRK subunit composition differs across 5-HT1A-expressing cell types unresolved"]},{"year":2005,"claim":"Demonstration that 5-HT1A activation inhibits NMDA-NR2B currents in PFC via microtubule destabilization and KIF17-dependent trafficking revealed a non-canonical effector pathway linking serotonin to glutamatergic synaptic plasticity.","evidence":"Patch-clamp in PFC slices, KIF17 siRNA, microtubule stability assays, immunocytochemistry","pmids":["15944377"],"confidence":"High","gaps":["Whether this pathway operates at autoreceptors or only heteroreceptors not tested","In vivo relevance to cognitive function not established"]},{"year":2008,"claim":"Identification of Yif1B as a C-terminal interactor required for dendritic targeting of 5-HT1A established a specific ER/Golgi trafficking mechanism for somatodendritic receptor localization.","evidence":"Yeast two-hybrid, GST pulldown from rat brain, siRNA in primary neurons","pmids":["18685031"],"confidence":"High","gaps":["Whether Yif1B loss affects autoreceptor function in vivo untested","Other trafficking partners not explored"]},{"year":2008,"claim":"FRET-based detection of palmitoylation-dependent homo-oligomers whose conformation changes upon agonist activation revealed that 5-HT1A functions as a dynamic oligomeric complex at the plasma membrane.","evidence":"Multiple FRET techniques in living N1E-115 cells with palmitoylation-deficient mutants","pmids":["18381076"],"confidence":"Medium","gaps":["Oligomeric stoichiometry and interface not structurally resolved","Functional significance of oligomerization for signaling not determined","Confirmed in only one cell line"]},{"year":2010,"claim":"Region-specific autoreceptor manipulation causally demonstrated that raphe 5-HT1A autoreceptor levels determine stress resilience and antidepressant response, separating autoreceptor from heteroreceptor functions in vivo.","evidence":"Conditional transgenic mice with raphe-specific autoreceptor level manipulation, electrophysiology, behavioral paradigms","pmids":["20152112"],"confidence":"High","gaps":["Molecular mechanism downstream of autoreceptor level changes not detailed","Translational relevance to human pharmacotherapy not directly tested"]},{"year":2010,"claim":"Genetic disruption of RGS regulation at Gαi2 selectively potentiated 5-HT1A-mediated antidepressant-like behavior, identifying RGS-Gαi2 as a key negative regulator constraining the receptor's therapeutic signaling axis.","evidence":"RGS-insensitive Gαi2 knock-in mice, WAY-100635 blockade, GSK-3β phosphorylation assays","pmids":["20534514"],"confidence":"High","gaps":["Which specific RGS family member(s) are responsible not identified","Whether RGS regulation differs between auto- and heteroreceptors unknown"]},{"year":2019,"claim":"Identification of miR-26a-2 as a direct post-transcriptional repressor of HTR1A in serotonergic neurons added a microRNA-based regulatory layer to autoreceptor expression control, with bidirectional effects on stress resilience.","evidence":"Luciferase reporter assays with Htr1a 5'UTR, serotonergic-neuron-specific transgenic gain/loss-of-function mice, reciprocal genetic rescue","pmids":["30808545"],"confidence":"Medium","gaps":["Endogenous miR-26a-2 levels in human raphe neurons not measured","Interaction with other post-transcriptional regulators not explored"]},{"year":2021,"claim":"Cryo-EM structures of 5-HT1A–Gi complexes resolved longstanding questions about how lipids regulate receptor function: PI4P at the G-protein interface enhances signaling, cholesterol shapes ligand selectivity, and structured waters maintain basal activity.","evidence":"Cryo-EM structure determination (apo, 5-HT-bound, aripiprazole-bound), PI4P functional assays, G-protein activation assays","pmids":["33762731"],"confidence":"High","gaps":["Structures determined in detergent/lipid nanodisc — native membrane environment effects not captured","Dynamic transitions between active and inactive states not resolved","Oligomeric state not visible in structures"]},{"year":null,"claim":"Key unresolved questions include the structural basis for cell-type-specific Gαi subtype selectivity, the identity of RGS proteins that constrain 5-HT1A signaling in vivo, and whether the oligomeric state observed by FRET is functionally relevant in native neurons.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structure of autoreceptor vs. heteroreceptor conformational differences","RGS family member identity at 5-HT1A not determined","In vivo functional consequence of oligomerization unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[1,2,5,6,9,10,19]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[2,8,14,15]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[1,12,15,19]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[11]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[2,3,5,10,13,19]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[8,14,15,22,23]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[4,7,24]}],"complexes":[],"partners":["GNAI2","GNAI3","GNAO1","YIF1B","MAZ","DEAF1","TRIM21","PSMD7"],"other_free_text":[]},"mechanistic_narrative":"HTR1A encodes the 5-hydroxytryptamine receptor 1A, a Gi/o-coupled GPCR that inhibits adenylyl cyclase at nanomolar serotonin concentrations and activates phospholipase C at higher agonist occupancy, both via pertussis toxin-sensitive G proteins, with cell-type-dependent preferential coupling to Gαi2 or Gαi3 [PMID:2549039, PMID:8218170]. As a somatodendritic autoreceptor in raphe serotonergic neurons, it opens GIRK channels to hyperpolarize neurons and set firing rate; genetic deletion nearly doubles raphe firing rate, and selective manipulation of autoreceptor levels causally determines stress resilience and antidepressant responsiveness [PMID:11821026, PMID:20152112, PMID:15306649]. Cryo-EM structures reveal that phosphatidylinositol 4-phosphate at the receptor–Gi interface enhances signaling, cholesterol directly shapes the ligand-binding pocket, and structured water molecules in the apo state maintain constitutive activity [PMID:33762731]. Transcription is driven by the MAZ/Sp1 promoter complex and repressed by NUDR/DEAF-1 at the C(-1019)G polymorphism—a variant associated with major depression and suicide—while glucocorticoids negatively regulate hippocampal HTR1A transcription and miR-26a-2 post-transcriptionally suppresses autoreceptor levels [PMID:8626793, PMID:14507979, PMID:7769998, PMID:30808545]."},"prefetch_data":{"uniprot":{"accession":"P08908","full_name":"5-hydroxytryptamine receptor 1A","aliases":["G-21","Serotonin receptor 1A"],"length_aa":422,"mass_kda":46.1,"function":"G-protein coupled receptor for 5-hydroxytryptamine (serotonin) (PubMed:22957663, PubMed:3138543, PubMed:33762731, PubMed:37935376, PubMed:37935377, PubMed:8138923, PubMed:8393041). Also functions as a receptor for various drugs and psychoactive substances (PubMed:22957663, PubMed:3138543, PubMed:33762731, PubMed:38552625, PubMed:8138923, PubMed:8393041). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of downstream effectors, such as adenylate cyclase (PubMed:22957663, PubMed:3138543, PubMed:33762731, PubMed:8138923, PubMed:8393041). HTR1A is coupled to G(i)/G(o) G alpha proteins and mediates inhibitory neurotransmission: signaling inhibits adenylate cyclase activity and activates a phosphatidylinositol-calcium second messenger system that regulates the release of Ca(2+) ions from intracellular stores (PubMed:33762731, PubMed:35610220). Beta-arrestin family members regulate signaling by mediating both receptor desensitization and resensitization processes (PubMed:18476671, PubMed:20363322, PubMed:20945968). Plays a role in the regulation of 5-hydroxytryptamine release and in the regulation of dopamine and 5-hydroxytryptamine metabolism (PubMed:18476671, PubMed:20363322, PubMed:20945968). Plays a role in the regulation of dopamine and 5-hydroxytryptamine levels in the brain, and thereby affects neural activity, mood and behavior (PubMed:18476671, PubMed:20363322, PubMed:20945968). Plays a role in the response to anxiogenic stimuli (PubMed:18476671, PubMed:20363322, PubMed:20945968)","subcellular_location":"Cell membrane; Cell projection, dendrite","url":"https://www.uniprot.org/uniprotkb/P08908/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/HTR1A","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/HTR1A","total_profiled":1310},"omim":[{"mim_id":"619109","title":"YIP1-INTERACTING FACTOR HOMOLOG B, MEMBRANE-TRAFFICKING PROTEIN; YIF1B","url":"https://www.omim.org/entry/619109"},{"mim_id":"617231","title":"PHOSPHOLYSINE PHOSPHOHISTIDINE INORGANIC PYROPHOSPHATE PHOSPHATASE; LHPP","url":"https://www.omim.org/entry/617231"},{"mim_id":"614674","title":"PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT","url":"https://www.omim.org/entry/614674"},{"mim_id":"600665","title":"MELATONIN RECEPTOR 1A; MTNR1A","url":"https://www.omim.org/entry/600665"},{"mim_id":"312861","title":"5-@HYDROXYTRYPTAMINE RECEPTOR 2C; HTR2C","url":"https://www.omim.org/entry/312861"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"brain","ntpm":6.1}],"url":"https://www.proteinatlas.org/search/HTR1A"},"hgnc":{"alias_symbol":["5-HT1A"],"prev_symbol":["ADRB2RL1","ADRBRL1"]},"alphafold":{"accession":"P08908","domains":[{"cath_id":"1.20.1070.10","chopping":"31-236_327-419","consensus_level":"high","plddt":91.7875,"start":31,"end":419}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P08908","model_url":"https://alphafold.ebi.ac.uk/files/AF-P08908-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P08908-F1-predicted_aligned_error_v6.png","plddt_mean":77.81},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=HTR1A","jax_strain_url":"https://www.jax.org/strain/search?query=HTR1A"},"sequence":{"accession":"P08908","fasta_url":"https://rest.uniprot.org/uniprotkb/P08908.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P08908/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P08908"}},"corpus_meta":[{"pmid":"16258853","id":"PMC_16258853","title":"Agonistic properties of cannabidiol at 5-HT1a receptors.","date":"2005","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/16258853","citation_count":654,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12063084","id":"PMC_12063084","title":"The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor.","date":"2002","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12063084","citation_count":444,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12559651","id":"PMC_12559651","title":"Is there a role for 5-HT1A agonists in the treatment of depression?","date":"2003","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/12559651","citation_count":439,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20152112","id":"PMC_20152112","title":"5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants.","date":"2010","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/20152112","citation_count":343,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2549039","id":"PMC_2549039","title":"Effector coupling mechanisms of the cloned 5-HT1A receptor.","date":"1989","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2549039","citation_count":272,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17316955","id":"PMC_17316955","title":"Serotonin and psychostimulant addiction: focus on 5-HT1A-receptors.","date":"2007","source":"Progress in neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/17316955","citation_count":249,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8365456","id":"PMC_8365456","title":"WAY100135: a novel, selective antagonist at presynaptic and postsynaptic 5-HT1A receptors.","date":"1993","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/8365456","citation_count":222,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11723272","id":"PMC_11723272","title":"Serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian models.","date":"2001","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/11723272","citation_count":200,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15944377","id":"PMC_15944377","title":"Serotonin 5-HT1A receptors regulate NMDA receptor channels through a microtubule-dependent mechanism.","date":"2005","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/15944377","citation_count":187,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11277607","id":"PMC_11277607","title":"The 5-HT1A receptor in schizophrenia: a promising target for novel atypical neuroleptics?","date":"2001","source":"Journal of psychopharmacology (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11277607","citation_count":183,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15306649","id":"PMC_15306649","title":"Serotonergic regulation of the orexin/hypocretin neurons through the 5-HT1A receptor.","date":"2004","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/15306649","citation_count":161,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26851834","id":"PMC_26851834","title":"The 5-HT1A receptor in Major Depressive Disorder.","date":"2016","source":"European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/26851834","citation_count":157,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31079617","id":"PMC_31079617","title":"The 5-HT1A receptor: Signaling to behavior.","date":"2018","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/31079617","citation_count":154,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18639564","id":"PMC_18639564","title":"Transcriptional regulation at a HTR1A polymorphism associated with mental illness.","date":"2008","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/18639564","citation_count":140,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21619616","id":"PMC_21619616","title":"Transcriptional dysregulation of 5-HT1A autoreceptors in mental illness.","date":"2011","source":"Molecular brain","url":"https://pubmed.ncbi.nlm.nih.gov/21619616","citation_count":121,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19124686","id":"PMC_19124686","title":"Effects of HTR1A C(-1019)G on amygdala reactivity and trait anxiety.","date":"2009","source":"Archives of general psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/19124686","citation_count":120,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22826341","id":"PMC_22826341","title":"Transcriptional regulation of the 5-HT1A receptor: implications for mental illness.","date":"2012","source":"Philosophical transactions of the Royal Society of London. Series B, Biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/22826341","citation_count":118,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15920501","id":"PMC_15920501","title":"Increased fear response to contextual cues in mice lacking the 5-HT1A receptor.","date":"2006","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15920501","citation_count":111,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2259248","id":"PMC_2259248","title":"Application of brain microdialysis to study the pharmacology of the 5-HT1A autoreceptor.","date":"1990","source":"Journal of neuroscience methods","url":"https://pubmed.ncbi.nlm.nih.gov/2259248","citation_count":100,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24935787","id":"PMC_24935787","title":"Interplay between serotonin 5-HT1A and 5-HT7 receptors in depressive disorders.","date":"2014","source":"CNS neuroscience & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/24935787","citation_count":94,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18268499","id":"PMC_18268499","title":"Evidence for HTR1A and LHPP as interacting genetic risk factors in major depression.","date":"2008","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/18268499","citation_count":90,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9768554","id":"PMC_9768554","title":"Alcohol-heightened aggression in mice: attenuation by 5-HT1A receptor agonists.","date":"1998","source":"Psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/9768554","citation_count":88,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17408646","id":"PMC_17408646","title":"Serotonin-1A receptor gene HTR1A variation predicts interferon-induced depression in chronic hepatitis C.","date":"2007","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/17408646","citation_count":84,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15689356","id":"PMC_15689356","title":"[11C]-WAY100635 PET demonstrates marked 5-HT1A receptor changes in sporadic ALS.","date":"2005","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/15689356","citation_count":84,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2282513","id":"PMC_2282513","title":"NAN-190: agonist and antagonist interactions with brain 5-HT1A receptors.","date":"1990","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/2282513","citation_count":83,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15023569","id":"PMC_15023569","title":"Decreased 5-HT1A receptor binding in amygdala of schizophrenia.","date":"2004","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/15023569","citation_count":82,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18484082","id":"PMC_18484082","title":"Effect of 5-HT1A gene polymorphisms on antidepressant response in major depressive disorder.","date":"2009","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18484082","citation_count":81,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26696889","id":"PMC_26696889","title":"Hippocampal 5-HT1A Receptor and Spatial Learning and Memory.","date":"2015","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/26696889","citation_count":81,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1387027","id":"PMC_1387027","title":"Evidence for postsynaptic mediation of the hypothermic effect of 5-HT1A receptor activation.","date":"1992","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/1387027","citation_count":80,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17401528","id":"PMC_17401528","title":"Interaction between 5-HT1A and BDNF genotypes increases the risk of treatment-resistant depression.","date":"2007","source":"Journal of neural transmission (Vienna, Austria : 1996)","url":"https://pubmed.ncbi.nlm.nih.gov/17401528","citation_count":76,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15064330","id":"PMC_15064330","title":"Desensitization of 5-HT1A receptors by 5-HT2A receptors in neuroendocrine neurons in vivo.","date":"2004","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/15064330","citation_count":69,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15145142","id":"PMC_15145142","title":"Mirtazapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation.","date":"2004","source":"Brain research bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/15145142","citation_count":69,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8158130","id":"PMC_8158130","title":"Hippocampal serotonin 5-HT1A receptor enhances acetylcholine release in conscious rats.","date":"1994","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8158130","citation_count":68,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21412223","id":"PMC_21412223","title":"Nicotine alters limbic function in adolescent rat by a 5-HT1A receptor mechanism.","date":"2011","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/21412223","citation_count":65,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8028227","id":"PMC_8028227","title":"Antiemetic effects of serotonergic 5-HT1A-receptor agonists in Suncus murinus.","date":"1994","source":"Japanese journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/8028227","citation_count":64,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7769998","id":"PMC_7769998","title":"Transcriptional regulation of hippocampal 5-HT1a receptors by corticosteroid hormones.","date":"1995","source":"Brain research. Molecular brain research","url":"https://pubmed.ncbi.nlm.nih.gov/7769998","citation_count":62,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9536453","id":"PMC_9536453","title":"Agonist and antagonist actions of (-)pindolol at recombinant, human serotonin1A (5-HT1A) receptors.","date":"1998","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/9536453","citation_count":62,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19829169","id":"PMC_19829169","title":"SSRI response in depression may be influenced by SNPs in HTR1B and HTR1A.","date":"2009","source":"Psychiatric genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19829169","citation_count":60,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22820867","id":"PMC_22820867","title":"Acute 5-HT₁A autoreceptor knockdown increases antidepressant responses and serotonin release in stressful conditions.","date":"2012","source":"Psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/22820867","citation_count":59,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18685031","id":"PMC_18685031","title":"Targeting of the 5-HT1A serotonin receptor to neuronal dendrites is mediated by Yif1B.","date":"2008","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/18685031","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20534514","id":"PMC_20534514","title":"RGS inhibition at G(alpha)i2 selectively potentiates 5-HT1A-mediated antidepressant effects.","date":"2010","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/20534514","citation_count":55,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16237386","id":"PMC_16237386","title":"Estrogen prevents 5-HT1A receptor-induced disruptions of prepulse inhibition in healthy women.","date":"2006","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/16237386","citation_count":54,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11821026","id":"PMC_11821026","title":"Modification of serotonin neuron properties in mice lacking 5-HT1A receptors.","date":"2002","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/11821026","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10617139","id":"PMC_10617139","title":"Mechanisms of agonism and inverse agonism at serotonin 5-HT1A receptors.","date":"2000","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10617139","citation_count":51,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19725031","id":"PMC_19725031","title":"Significant association between the C(-1019)G functional polymorphism of the HTR1A gene and impulsivity.","date":"2010","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19725031","citation_count":51,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31054943","id":"PMC_31054943","title":"Cannabidiol attenuates aggressive behavior induced by social isolation in mice: Involvement of 5-HT1A and CB1 receptors.","date":"2019","source":"Progress in neuro-psychopharmacology & biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/31054943","citation_count":51,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10082640","id":"PMC_10082640","title":"5-HT1A receptors modulate the consolidation of learning in normal and cognitively impaired rats.","date":"1999","source":"Neurobiology of learning and memory","url":"https://pubmed.ncbi.nlm.nih.gov/10082640","citation_count":51,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1524716","id":"PMC_1524716","title":"Antipeptide antibodies against the 5-HT1A receptor.","date":"1992","source":"Journal of chemical neuroanatomy","url":"https://pubmed.ncbi.nlm.nih.gov/1524716","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9806333","id":"PMC_9806333","title":"Analysis of the 5-HT1A receptor involvement in passive avoidance in the rat.","date":"1998","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/9806333","citation_count":49,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17803293","id":"PMC_17803293","title":"High-efficacy 5-HT1A agonists for antidepressant treatment: a renewed opportunity.","date":"2007","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17803293","citation_count":49,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8855520","id":"PMC_8855520","title":"New 5-HT1A receptor antagonist: [3H]p-MPPF.","date":"1996","source":"Synapse (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/8855520","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9749777","id":"PMC_9749777","title":"Intraventricular galanin modulates a 5-HT1A receptor-mediated behavioural response in the rat.","date":"1998","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/9749777","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25363799","id":"PMC_25363799","title":"The phytocannabinoid, Δ⁹-tetrahydrocannabivarin, can act through 5-HT₁A receptors to produce antipsychotic effects.","date":"2015","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/25363799","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27897266","id":"PMC_27897266","title":"Evaluation of association of common variants in HTR1A and HTR5A with schizophrenia and executive function.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27897266","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12480124","id":"PMC_12480124","title":"Effects of ethanol and 5-HT1A agonists on astroglial S100B.","date":"2002","source":"Brain research. Developmental brain research","url":"https://pubmed.ncbi.nlm.nih.gov/12480124","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21036859","id":"PMC_21036859","title":"Brainstem changes in 5-HT1A receptor availability during migraine attack.","date":"2010","source":"Cephalalgia : an international journal of headache","url":"https://pubmed.ncbi.nlm.nih.gov/21036859","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14985704","id":"PMC_14985704","title":"Occupancy of agonist drugs at the 5-HT1A receptor.","date":"2004","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/14985704","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18381076","id":"PMC_18381076","title":"Stimulation- and palmitoylation-dependent changes in oligomeric conformation of serotonin 5-HT1A receptors.","date":"2008","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/18381076","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25913021","id":"PMC_25913021","title":"5-HT1A Receptor-Mediated Autoinhibition and the Control of Serotonergic Cell Firing.","date":"2015","source":"ACS chemical neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25913021","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1436390","id":"PMC_1436390","title":"Desensitization of 5-HT1A autoreceptors by chronic administration of 8-OH-DPAT.","date":"1992","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/1436390","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7838929","id":"PMC_7838929","title":"Effects of glucocorticoids on 5-HT1A presynaptic function in the mouse.","date":"1994","source":"Psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/7838929","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20025927","id":"PMC_20025927","title":"Polymorphisms of the HTR1a allele are linked to frontal brain electrical asymmetry.","date":"2009","source":"Biological psychology","url":"https://pubmed.ncbi.nlm.nih.gov/20025927","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9754943","id":"PMC_9754943","title":"The 5-HT1A receptor agonist BAY x 3702 prevents staurosporine-induced apoptosis.","date":"1998","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/9754943","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18094064","id":"PMC_18094064","title":"Activation of 5-HT1A receptors in medullary raphé disrupts sleep and decreases shivering during cooling in the conscious piglet.","date":"2007","source":"American journal of physiology. Regulatory, integrative and comparative physiology","url":"https://pubmed.ncbi.nlm.nih.gov/18094064","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20638825","id":"PMC_20638825","title":"The HTR1A and HTR1B receptor genes influence stress-related information processing.","date":"2010","source":"European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/20638825","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14654304","id":"PMC_14654304","title":"Opioid hyperalgesia and tolerance versus 5-HT1A receptor-mediated inverse tolerance.","date":"2003","source":"Trends in pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/14654304","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8788494","id":"PMC_8788494","title":"Development of 5-HT1A receptor antagonists.","date":"1996","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/8788494","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23216389","id":"PMC_23216389","title":"Genome-wide significant association signals in IPO11-HTR1A region specific for alcohol and nicotine codependence.","date":"2012","source":"Alcoholism, clinical and experimental research","url":"https://pubmed.ncbi.nlm.nih.gov/23216389","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17167032","id":"PMC_17167032","title":"Native rat hippocampal 5-HT1A receptors show constitutive activity.","date":"2006","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/17167032","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8720582","id":"PMC_8720582","title":"Effects of K+ channel blockers and openers on antinociception induced by agonists of 5-HT1A receptors.","date":"1996","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/8720582","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25514753","id":"PMC_25514753","title":"The functional -1019C/G HTR1A polymorphism and mechanisms of fear.","date":"2014","source":"Translational psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/25514753","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2569265","id":"PMC_2569265","title":"Involvement of brain 5-HT1A receptors in the hypotensive response to urapidil.","date":"1989","source":"The American journal of cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/2569265","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31765686","id":"PMC_31765686","title":"Dopaminergic neuroprotective effects of rotigotine via 5-HT1A receptors: Possibly involvement of metallothionein expression in astrocytes.","date":"2019","source":"Neurochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/31765686","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16952161","id":"PMC_16952161","title":"Quantification of serotonin 5-HT1A receptors in monkey brain with [11C](R)-(-)-RWAY.","date":"2006","source":"Synapse (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/16952161","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30808545","id":"PMC_30808545","title":"MicroRNA-26a-2 maintains stress resiliency and antidepressant efficacy by targeting the serotonergic autoreceptor HTR1A.","date":"2019","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/30808545","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22575584","id":"PMC_22575584","title":"Sensitivity of hippocampal 5-HT1A receptors to mild stress in BDNF-deficient mice.","date":"2012","source":"The international journal of neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/22575584","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21051107","id":"PMC_21051107","title":"Regulation of cortical and striatal 5-HT1A receptors in the MPTP-lesioned macaque.","date":"2010","source":"Neurobiology of aging","url":"https://pubmed.ncbi.nlm.nih.gov/21051107","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22788968","id":"PMC_22788968","title":"The therapeutic potential of 5-HT1A receptors: a patent review.","date":"2012","source":"Expert opinion on therapeutic patents","url":"https://pubmed.ncbi.nlm.nih.gov/22788968","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22050410","id":"PMC_22050410","title":"Effect of buspirone, a 5-HT1A receptor agonist, on esophageal motility in healthy volunteers.","date":"2011","source":"Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus","url":"https://pubmed.ncbi.nlm.nih.gov/22050410","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20089082","id":"PMC_20089082","title":"Efficacy of a 5-HT1a receptor agonist in atopic dermatitis.","date":"2010","source":"Clinical and experimental dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/20089082","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26441141","id":"PMC_26441141","title":"TREK1 channel blockade induces an antidepressant-like response synergizing with 5-HT1A receptor signaling.","date":"2015","source":"European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/26441141","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1816558","id":"PMC_1816558","title":"Structure-activity relationships at 5-HT1A receptors: binding profiles and intrinsic activity.","date":"1991","source":"Pharmacology, biochemistry, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/1816558","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34458005","id":"PMC_34458005","title":"The epigenetic role of HTR1A antagonist in facilitaing GnRH expression for pubertal initiation control.","date":"2021","source":"Molecular therapy. Nucleic acids","url":"https://pubmed.ncbi.nlm.nih.gov/34458005","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10821446","id":"PMC_10821446","title":"Modulation of 5-HT1A receptor mediated response by fluoxetine in rat brain.","date":"2000","source":"Journal of neural transmission (Vienna, Austria : 1996)","url":"https://pubmed.ncbi.nlm.nih.gov/10821446","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26366943","id":"PMC_26366943","title":"Yohimbine is a 5-HT1A agonist in rats in doses exceeding 1 mg/kg.","date":"2015","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/26366943","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2052135","id":"PMC_2052135","title":"The 5-HT1A receptor: an overview of recent advances.","date":"1991","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/2052135","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17284006","id":"PMC_17284006","title":"Screening of 5-HT1A receptor antagonists using molecularly imprinted polymers.","date":"2007","source":"Journal of the American Chemical Society","url":"https://pubmed.ncbi.nlm.nih.gov/17284006","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8888384","id":"PMC_8888384","title":"Effects of the 5-HT1A receptor agonist flesinoxan in panic disorder.","date":"1996","source":"Psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/8888384","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7909594","id":"PMC_7909594","title":"Anxiolytic and antidepressant mechanisms of 5-HT1A drugs in the pigeon: contributions from behavioral studies.","date":"1994","source":"Neuroscience and biobehavioral reviews","url":"https://pubmed.ncbi.nlm.nih.gov/7909594","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24258351","id":"PMC_24258351","title":"Activation of postsynaptic 5-HT1A receptors improve stress adaptation.","date":"2013","source":"Psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/24258351","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11697552","id":"PMC_11697552","title":"Rectal antinociceptive properties of alverine citrate are linked to antagonism at the 5-HT1A receptor subtype.","date":"2001","source":"The Journal of pharmacy and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/11697552","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30124346","id":"PMC_30124346","title":"5-HT1A receptor ligands and their therapeutic applications: review of new patents.","date":"2018","source":"Expert opinion on therapeutic patents","url":"https://pubmed.ncbi.nlm.nih.gov/30124346","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8891585","id":"PMC_8891585","title":"Binding thermodynamics of 5-HT1A receptor ligands.","date":"1996","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/8891585","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9255714","id":"PMC_9255714","title":"The ligand-binding site of buspirone analogues at the 5-HT1A receptor.","date":"1997","source":"The Journal of pharmacy and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/9255714","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23336048","id":"PMC_23336048","title":"A subpopulation of serotonergic neurons that do not express the 5-HT1A autoreceptor.","date":"2012","source":"ACS chemical neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23336048","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27244650","id":"PMC_27244650","title":"Mechanistic Studies on the Stereoselectivity of the Serotonin 5-HT1A Receptor.","date":"2016","source":"Angewandte Chemie (International ed. in English)","url":"https://pubmed.ncbi.nlm.nih.gov/27244650","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35199941","id":"PMC_35199941","title":"HTR1A Inhibits the Progression of Triple-Negative Breast Cancer via TGF-β Canonical and Noncanonical Pathways.","date":"2022","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/35199941","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23992341","id":"PMC_23992341","title":"PET radiotracers for molecular imaging of serotonin 5-HT1A receptors.","date":"2014","source":"Current medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23992341","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16147954","id":"PMC_16147954","title":"Treatment of cerebellar ataxia with 5-HT1A agonist.","date":"2005","source":"Cerebellum (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/16147954","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1684526","id":"PMC_1684526","title":"5-HT1A agonists uncouple noradrenergic somatodendritic impulse flow and terminal release.","date":"1991","source":"Brain research bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/1684526","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20935630","id":"PMC_20935630","title":"Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index.","date":"2010","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20935630","citation_count":2251,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"3138543","id":"PMC_3138543","title":"The genomic clone G-21 which resembles a beta-adrenergic receptor sequence encodes the 5-HT1A receptor.","date":"1988","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/3138543","citation_count":575,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14507979","id":"PMC_14507979","title":"Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide.","date":"2003","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/14507979","citation_count":517,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"3041227","id":"PMC_3041227","title":"An intronless gene encoding a potential member of the family of receptors coupled to guanine nucleotide regulatory proteins.","date":"1987","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/3041227","citation_count":492,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16344560","id":"PMC_16344560","title":"Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.","date":"2005","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16344560","citation_count":409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18982004","id":"PMC_18982004","title":"Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder.","date":"2008","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/18982004","citation_count":350,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9736659","id":"PMC_9736659","title":"Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity.","date":"1998","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/9736659","citation_count":336,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16154547","id":"PMC_16154547","title":"Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study.","date":"2005","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/16154547","citation_count":270,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18394726","id":"PMC_18394726","title":"The role of 5-HT(1A) receptors in learning and memory.","date":"2008","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/18394726","citation_count":268,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14736842","id":"PMC_14736842","title":"Reduced serotonin type 1A receptor binding in panic disorder.","date":"2004","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/14736842","citation_count":262,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"2834384","id":"PMC_2834384","title":"Presence of three distinct molecular species of Gi protein alpha subunit. Structure of rat cDNAs and human genomic DNAs.","date":"1988","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2834384","citation_count":256,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14744462","id":"PMC_14744462","title":"Serotonin 5-HT1A, 5-HT1B, and 5-HT2A receptor mRNA expression in subjects with major depression, bipolar disorder, and schizophrenia.","date":"2004","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/14744462","citation_count":229,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20124538","id":"PMC_20124538","title":"Brainstem serotonergic deficiency in sudden infant death syndrome.","date":"2010","source":"JAMA","url":"https://pubmed.ncbi.nlm.nih.gov/20124538","citation_count":228,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20351714","id":"PMC_20351714","title":"Poor replication of candidate genes for major depressive disorder using genome-wide association data.","date":"2010","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/20351714","citation_count":220,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33762731","id":"PMC_33762731","title":"Structural insights into the lipid and ligand regulation of serotonin receptors.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/33762731","citation_count":217,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15758168","id":"PMC_15758168","title":"A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans.","date":"2005","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/15758168","citation_count":200,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8626793","id":"PMC_8626793","title":"The serotonin 1a receptor gene contains a TATA-less promoter that responds to MAZ and Sp1.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8626793","citation_count":200,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15052272","id":"PMC_15052272","title":"Investigation of serotonin-related genes in antidepressant response.","date":"2004","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/15052272","citation_count":192,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12650852","id":"PMC_12650852","title":"5-HT2A and 5-HT2C receptors and their atypical regulation properties.","date":"2003","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/12650852","citation_count":175,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14666415","id":"PMC_14666415","title":"Allelic variation in 5-HT1A receptor expression is associated with anxiety- and depression-related personality traits.","date":"2003","source":"Journal of neural transmission (Vienna, Austria : 1996)","url":"https://pubmed.ncbi.nlm.nih.gov/14666415","citation_count":171,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12559389","id":"PMC_12559389","title":"Regulation of 5-HT1A receptor function in brain following agonist or antidepressant administration.","date":"2003","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/12559389","citation_count":163,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28470485","id":"PMC_28470485","title":"Biomarkers of Suicide Attempt Behavior: Towards a Biological Model of Risk.","date":"2017","source":"Current psychiatry reports","url":"https://pubmed.ncbi.nlm.nih.gov/28470485","citation_count":159,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15447813","id":"PMC_15447813","title":"Association of the C(-1019)G 5-HT1A functional promoter polymorphism with antidepressant response.","date":"2004","source":"The international journal of neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15447813","citation_count":151,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16302021","id":"PMC_16302021","title":"Response to fluoxetine and serotonin 1A receptor (C-1019G) polymorphism in Taiwan Chinese major depressive disorder.","date":"2006","source":"The pharmacogenomics journal","url":"https://pubmed.ncbi.nlm.nih.gov/16302021","citation_count":148,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8218170","id":"PMC_8218170","title":"Cell-specific physical and functional coupling of human 5-HT1A receptors to inhibitory G protein alpha-subunits and lack of coupling to Gs alpha.","date":"1993","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8218170","citation_count":145,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15111672","id":"PMC_15111672","title":"Limbic reductions of 5-HT1A receptor binding in human temporal lobe epilepsy.","date":"2004","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/15111672","citation_count":144,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19900711","id":"PMC_19900711","title":"Altered expression of CD4(+)CD25(+) regulatory T cells and its 5-HT(1a) receptor in patients with major depression disorder.","date":"2009","source":"Journal of affective disorders","url":"https://pubmed.ncbi.nlm.nih.gov/19900711","citation_count":137,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":52357,"output_tokens":6116,"usd":0.124406},"stage2":{"model":"claude-opus-4-6","input_tokens":9755,"output_tokens":3108,"usd":0.189713},"total_usd":0.684749,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":68712,"output_tokens":6514,"usd":0.151923},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":10346,"output_tokens":3763,"usd":0.218707}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1989,\n      \"finding\": \"The cloned human 5-HT1A receptor couples to multiple G protein-mediated signal transduction pathways: it inhibits adenylyl cyclase (cAMP production) via pertussis toxin-sensitive G-proteins (EC50 ~20 nM), and at higher concentrations stimulates phospholipase C to produce inositol phosphates; both pathways are blocked by pertussis toxin, indicating Gi/Go coupling.\",\n      \"method\": \"Transient and stable expression of cloned human 5-HT1A receptor in COS-7 and HeLa cells; cAMP assay; inositol phosphate assay; pertussis toxin pretreatment; competitive antagonism with metitepine and spiperone\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in transfected mammalian cells with multiple functional assays and pharmacological validation; foundational paper with 272 citations\",\n      \"pmids\": [\"2549039\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"5-HT1A receptor activation inhibits NR2B-containing NMDA receptor currents in prefrontal cortex pyramidal neurons through a microtubule/kinesin (KIF17)-dependent dendritic trafficking mechanism regulated by CaMKII and MEK/ERK signaling, reducing surface NR2B subunit density on dendrites.\",\n      \"method\": \"Whole-cell patch-clamp recordings in rat PFC neurons; siRNA knockdown of KIF17; pharmacological inhibitors of microtubule assembly, CaMKII, and MEK/ERK; immunocytochemistry for surface NR2B; biochemical microtubule stability assays\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods including electrophysiology, siRNA, pharmacology, and immunocytochemistry in a single study; 187 citations\",\n      \"pmids\": [\"15944377\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The 5-HT1A receptor is targeted specifically to neuronal dendrites via interaction of its C-terminal 17 amino acid domain with the intracellular trafficking protein Yif1B (a mammalian homolog of yeast Yif1p involved in ER-to-Golgi vesicular transport); siRNA knockdown of Yif1B selectively prevents 5-HT1A receptor addressing to distal dendrites without affecting other receptors.\",\n      \"method\": \"Yeast two-hybrid screen with 5-HT1A C-terminal domain as bait; GST pull-down with rat brain extracts and transfected cell lines; immunofluorescence colocalization; siRNA knockdown of Yif1B in primary neuron cultures\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (Y2H, GST pull-down, siRNA, live imaging) in a single rigorous study\",\n      \"pmids\": [\"18685031\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"RGS proteins acting at Gαi2 suppress 5-HT1A receptor-mediated antidepressant-like behavioral effects and GSK-3β phosphorylation; mice with RGS-insensitive Gαi2 (G184S knock-in) show spontaneous antidepressant/anxiolytic behavior and enhanced cortical/hippocampal GSK-3β phosphorylation, both blocked by the 5-HT1A antagonist WAY 100635, establishing Gαi2 as the primary downstream G protein mediating antidepressant-relevant 5-HT1A signaling.\",\n      \"method\": \"Gαi2 G184S knock-in mice; forced swim and open field behavioral assays; Western blot for phospho-GSK-3β; pharmacological blockade with WAY 100635; 8-OH-DPAT and fluvoxamine dose-response curves\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis combined with pharmacological rescue and biochemical endpoints in a single rigorous study\",\n      \"pmids\": [\"20534514\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"5-HT1A autoreceptor levels in raphe nuclei causally determine raphe firing rates, vulnerability to stress-induced behavioral despair, and antidepressant responsiveness; mice engineered with higher autoreceptor levels show blunted stress responses and fail to respond to antidepressants, while reducing autoreceptor levels converts non-responders to responders.\",\n      \"method\": \"Conditional transgenic mice with selectively elevated or reduced 5-HT1A autoreceptor expression in raphe; in vivo electrophysiology of raphe firing; forced swim and tail suspension behavioral tests; fluoxetine antidepressant treatment\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic manipulation with defined cellular phenotype replicated across multiple behavioral and physiological readouts; 343 citations\",\n      \"pmids\": [\"20152112\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"5-HT hyperpolarizes orexin/hypocretin neurons through 5-HT1A receptors by activating G protein-coupled inward rectifier potassium (GIRK) channels (single-channel conductance ~33.8 pS), as shown by patch-clamp recordings in hypothalamic slices from orexin-EGFP transgenic mice; this inhibitory input is functionally relevant for locomotor activity regulation.\",\n      \"method\": \"Patch-clamp recordings (whole-cell and single-channel) in hypothalamic slices from orexin/EGFP transgenic mice; Ba2+ block; WAY100635 antagonism; intracerebroventricular WAY100635 injection in wild-type vs. orexin/ataxin-3 mice; immunohistochemistry for 5-HT1A receptor on orexin neurons\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct electrophysiology including single-channel recordings, pharmacological validation, and in vivo functional confirmation with genetic control animals\",\n      \"pmids\": [\"15306649\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Cannabidiol (CBD) acts as a modest-affinity agonist at the cloned human 5-HT1A receptor: it displaces [3H]8-OH-DPAT binding in a concentration-dependent manner and increases [35S]GTPγS binding, and decreases cAMP at similar receptor occupancy levels as 5-HT, demonstrating functional agonism at this Gi-coupled receptor.\",\n      \"method\": \"Radioligand displacement assay ([3H]8-OH-DPAT) at cloned human 5-HT1A receptor; [35S]GTPγS binding assay; cAMP assay in GPCR system\",\n      \"journal\": \"Neurochemical research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple functional assays in a single study with cloned human receptor; single laboratory\",\n      \"pmids\": [\"16258853\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Aripiprazole acts as a potent partial agonist at the cloned human 5-HT1A receptor with high binding affinity, as demonstrated by [35S]GTPγS binding that is fully blocked by a selective 5-HT1A antagonist.\",\n      \"method\": \"[35S]GTPγS binding assay in CHO cell membranes expressing recombinant human 5-HT1A receptor; radioligand binding\",\n      \"journal\": \"European journal of pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — direct functional assay at cloned human receptor; single study\",\n      \"pmids\": [\"12063084\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Mechanistic analysis of agonism and inverse agonism at 5-HT1A receptors shows: agonists increase [35S]GTPγS binding by stabilizing the receptor-G protein ternary complex; spiperone acts as an inverse agonist by stabilizing uncoupled receptor forms; methiothepin inverse agonism may stabilize an inactive receptor conformation that retains G protein coupling. Sodium ions modulate maximal agonist efficacy but not agonist potency or inverse agonist actions.\",\n      \"method\": \"[35S]GTPγS binding assay in CHO cells expressing human 5-HT1A receptors; GDP and sodium ion concentration variation; extended ternary complex model simulation\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — rigorous in vitro mechanistic study with systematic pharmacological dissection; single lab\",\n      \"pmids\": [\"10617139\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The 5-HT1A receptor forms homo-oligomers (predominantly dimers) at the plasma membrane; agonist stimulation induces a conformational change in oligomers (detected as decreased FRET efficiency) without dissociation, and this conformational change requires receptor palmitoylation—non-palmitoylated receptor mutants fail to undergo the agonist-induced oligomeric conformational shift.\",\n      \"method\": \"Biochemical analysis in neuroblastoma N1E-115 cells; acceptor photobleaching FRET; fluorescence lifetime imaging (FLIM-FRET); spectral FRET analysis; site-directed mutagenesis of palmitoylation sites\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple FRET methods with mutagenesis in a single study; single laboratory\",\n      \"pmids\": [\"18381076\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Native rat hippocampal 5-HT1A receptors exhibit constitutive G protein (Gαo) activity in vitro; spiperone and methiothepin reduce basal [35S]GTPγS binding as inverse agonists at these native receptors, and both effects are antagonized by WAY100635, confirming 5-HT1A receptor mediation.\",\n      \"method\": \"Anti-Gαo-antibody capture coupled to scintillation proximity assay; [35S]GTPγS binding in native rat hippocampal membranes under low sodium conditions; WAY100635 antagonism\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — demonstrated in native tissue with receptor-selective pharmacological controls; single laboratory\",\n      \"pmids\": [\"17167032\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"(-)Pindolol acts as a weak partial agonist (20% efficacy relative to 5-HT) at recombinant human 5-HT1A receptors expressed in CHO cells, as demonstrated by [35S]GTPγS binding, and also antagonizes 5-HT-stimulated [35S]GTPγS binding.\",\n      \"method\": \"[35S]GTPγS binding assay; radioligand binding in CHO-h5-HT1A cells\",\n      \"journal\": \"Neuropsychopharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — direct functional assay at cloned human receptor; single study, single lab\",\n      \"pmids\": [\"9536453\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"5-HT2A receptor activation in hypothalamic paraventricular nucleus PVN induces heterologous desensitization of 5-HT1A receptors on the same neuroendocrine cells (colocalized by double-label immunocytochemistry), reducing oxytocin and ACTH responses to 5-HT1A agonist; this is prevented by intra-PVN microinjection of a selective 5-HT2A antagonist.\",\n      \"method\": \"In vivo pharmacological challenge (DOI + 8-OH-DPAT); intra-PVN microinjection of MDL100907; plasma oxytocin and ACTH measurement; double-label immunocytochemistry for 5-HT1A and 5-HT2A in PVN neurons\",\n      \"journal\": \"The Journal of pharmacology and experimental therapeutics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological epistasis with microinjection localization and immunocytochemical colocalization; single laboratory\",\n      \"pmids\": [\"15064330\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Corticosteroid hormones negatively regulate 5-HT1A receptor gene transcription in hippocampus: adrenalectomy increases 5-HT1A mRNA and transcription rate (by ~70% in nuclear run-on assays), whereas dexamethasone prevents these increases, indicating direct transcriptional repression by glucocorticoids.\",\n      \"method\": \"In situ hybridization; RNase protection assay; nuclear run-on transcription assay; adrenalectomy and dexamethasone administration in rats\",\n      \"journal\": \"Brain research. Molecular brain research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — nuclear run-on directly measures transcription rate; multiple methods; single lab\",\n      \"pmids\": [\"7769998\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Molecular dynamics simulations of agonist vs. antagonist diastereomers binding to 5-HT1A receptor revealed that the agonist mobilizes key amino acid residues to form a continuous intracellular water channel (a molecular switch for activation), while the antagonist epimer remains stably docked without inducing this conformational change.\",\n      \"method\": \"All-atom long-timescale molecular dynamics simulations; molecular interaction fingerprints; structural comparison of two diastereomers of dihydrofuroaporphine\",\n      \"journal\": \"Angewandte Chemie (International ed. in English)\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 — computational only, no experimental structural or functional validation in this paper\",\n      \"pmids\": [\"27244650\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"5-HT1A autoreceptors in the dorsal raphe nucleus tonically inhibit 5-HT release in the hippocampus; 5-HT1A agonists including 8-OH-DPAT reduce extracellular 5-HT as measured by in vivo microdialysis, and this effect is sensitive to pindolol, confirming the 5-HT1A receptor mediates this autoinhibitory control of serotonin release.\",\n      \"method\": \"In vivo microdialysis in anesthetized rats; HPLC measurement of extracellular 5-HT; pharmacological antagonism with pindolol\",\n      \"journal\": \"Journal of neuroscience methods\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct in vivo measurement of 5-HT release with pharmacological controls; replicated across multiple 5-HT1A agonists\",\n      \"pmids\": [\"2259248\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"5-HT1A receptor activation in dorsal hippocampus enhances spontaneous acetylcholine release: local perfusion of the 5-HT1A agonist 8-OH-DPAT increased extracellular ACh, and this effect was fully abolished by the 5-HT1A antagonist NAN-190, whereas 5-HT1B receptor activation decreased ACh release.\",\n      \"method\": \"In vivo microdialysis in freely moving rats; local hippocampal perfusion of 8-OH-DPAT and NAN-190; electrochemical detection of ACh\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct local pharmacology with receptor-selective antagonist confirmation in vivo\",\n      \"pmids\": [\"8158130\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"miR-26a-2 functions as an endogenous repressor of 5-HT1A autoreceptor (HTR1A) expression in serotonergic neurons; overexpression of miR-26a-2 in 5-HT neurons improves stress resilience and antidepressant response, effects abolished by simultaneous HTR1A overexpression; knockdown of miR-26a-2 increases anxiety and weakens antidepressant response, rescued by HTR1A silencing.\",\n      \"method\": \"Reporter assay with Htr1a 5'UTR; conditional transgenic mouse models; chronic social defeat paradigm; elevated plus-maze, open-field, forced-swim tests; in vivo lentiviral knockdown/overexpression\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — epistasis confirmed by both gain- and loss-of-function with genetic rescue; single laboratory\",\n      \"pmids\": [\"30808545\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"HTR1A antagonism in GnRH neuronal cells upregulates GnRH expression via suppression of PI3K/Akt and MAPK/ERK pathways, leading to reduced CBX4 (a PRC1 component) expression, degradation of the PRC1 complex, and loss of H2AK119 ubiquitination at the GnRH promoter.\",\n      \"method\": \"WAY-100635 treatment of GT1-7 GnRH neuronal cells; RNA-seq; ChIP-seq for CBX4 and H2AK119ub; co-immunoprecipitation for RING2/YY1/CBX4 interactions; pathway inhibitor experiments\",\n      \"journal\": \"Molecular therapy. Nucleic acids\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (RNA-seq, ChIP-seq, Co-IP) in a single study; single laboratory\",\n      \"pmids\": [\"34458005\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"HTR1A interacts with TRIM21 and PSMD7 to inhibit ubiquitin-proteasome-mediated degradation of TβRII, thereby suppressing TGF-β canonical and non-canonical signaling in triple-negative breast cancer cells.\",\n      \"method\": \"siRNA screen; co-immunoprecipitation assays; RNA-seq; in vivo and in vitro functional experiments in breast cancer cells\",\n      \"journal\": \"Advanced science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP identifying protein interactions combined with functional RNA-seq and in vivo validation; single laboratory\",\n      \"pmids\": [\"35199941\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"Chronic (7-day but not 1-day) administration of 8-OH-DPAT desensitizes 5-HT1A autoreceptors, as measured by attenuated ability of acute 8-OH-DPAT challenge to reduce striatal 5-HT release in vivo.\",\n      \"method\": \"In vivo microdialysis in rats; chronic 8-OH-DPAT treatment; HPLC measurement of striatal extracellular 5-HT\",\n      \"journal\": \"Neuropharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct functional measure of autoreceptor desensitization in vivo; single lab\",\n      \"pmids\": [\"1436390\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Genetic deletion of 5-HT1A receptors in null mutant mice nearly doubles the mean firing rate of dorsal raphe 5-HT neurons (recorded by extracellular electrophysiology), demonstrating autoreceptor-mediated tonic inhibition of serotonergic neuron activity; 5-HT1B autoreceptor function and α2-adrenergic heteroreceptor function are unchanged.\",\n      \"method\": \"Extracellular electrophysiological recordings in 5-HT1A-/- mice; brain slice preloaded with [3H]5-HT or [3H]NE; electrically evoked release assays\",\n      \"journal\": \"European journal of pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic knockout with direct electrophysiological readout plus neurochemical confirmation of pathway specificity\",\n      \"pmids\": [\"11821026\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"A subpopulation (~16%) of raphe serotonergic neurons does not express 5-HT1A autoreceptor mRNA; these 5-HT1A-negative neurons show no difference in passive membrane properties but fire more action potentials upon large depolarizing current injection, indicating absence of autoinhibitory feedback from local 5-HT release.\",\n      \"method\": \"Histochemistry in ePet1-eGFP and 5-HT1A-iCre/R26R mice; patch-clamp recordings of 134 raphe neurons followed by single-cell PCR for 5-HT1A mRNA\",\n      \"journal\": \"ACS chemical neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — single-cell PCR combined with electrophysiology; single laboratory\",\n      \"pmids\": [\"23336048\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"HTR1A (5-HT1A receptor) is a Gi/Go-coupled GPCR that, upon serotonin binding, inhibits adenylyl cyclase and reduces cAMP, opens GIRK potassium channels to hyperpolarize neurons (especially serotonergic raphe neurons as a somatodendritic autoreceptor and postsynaptic neurons), and signals through Gβγ to regulate CaMKII, ERK, and PI3K/Akt pathways; its dendritic targeting requires interaction with the trafficking protein Yif1B, its oligomeric conformation is regulated by palmitoylation and agonist binding, it forms heterodimers with 5-HT7 receptors, it undergoes desensitization upon chronic agonist exposure, its expression is transcriptionally repressed by glucocorticoids and by factors (Deaf1, Hes1, Hes5) at the C(-1019)G promoter polymorphism selectively in raphe autoreceptors, and autoreceptor level causally controls raphe firing rate, stress resilience, and antidepressant response.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1987,\n      \"finding\": \"The HTR1A gene is an intronless gene encoding a G-protein-coupled receptor with structural homology to adrenergic receptors, identified by cross-hybridization with a beta-2 adrenergic receptor probe.\",\n      \"method\": \"Molecular cloning and DNA sequencing\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — original cloning and sequencing of the gene, foundational paper with >400 citations\",\n      \"pmids\": [\"3041227\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1988,\n      \"finding\": \"The protein product of genomic clone G-21 (HTR1A) transiently expressed in monkey kidney cells displays all typical ligand-binding characteristics of the 5-HT1A receptor, establishing the identity of the cloned gene.\",\n      \"method\": \"Transient expression in COS-7 cells with radioligand binding assays\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct functional reconstitution of cloned receptor in mammalian cells, >500 citations\",\n      \"pmids\": [\"3138543\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1989,\n      \"finding\": \"The cloned human 5-HT1A receptor couples to multiple signal transduction pathways via pertussis toxin-sensitive G-proteins: it inhibits adenylyl cyclase (EC50 ~20 nM for 5-HT) and, at higher agonist concentrations, stimulates phospholipase C. No stimulation of adenylyl cyclase was observed.\",\n      \"method\": \"Transient (COS-7) and stable (HeLa) expression, cAMP and inositol phosphate assays, pertussis toxin treatment\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted receptor signaling in two cell lines with multiple orthogonal functional assays and pharmacological controls; >270 citations\",\n      \"pmids\": [\"2549039\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"Human 5-HT1A receptors physically and functionally couple to multiple Gi alpha subunits (Gi-alpha1, Gi-alpha2, Gi-alpha3) in a cell-type-dependent manner: Gi-alpha3 predominates in HeLa cells while Gi-alpha2 predominates in CHO-K1 cells. No physical or functional coupling to Gs alpha was detected. Agonist promotes receptor–G protein co-immunoprecipitation.\",\n      \"method\": \"Co-immunoprecipitation, high-affinity agonist binding, adenylyl cyclase inhibition assays with Gi-subtype-specific antisera in two cell lines\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — reciprocal co-immunoprecipitation and functional reconstitution with multiple G-protein subunit antisera in two independent cell systems\",\n      \"pmids\": [\"8218170\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"The 5-HT1A receptor gene contains a TATA-less, GC-rich promoter. Transcription factors MAZ (Pur-1/Zif87) and Sp1 bind to GC-rich elements in the promoter; overexpression of MAZ or Sp1 increases reporter expression, with MAZ being substantially more effective. An initiator-like element was also identified.\",\n      \"method\": \"RNA 5'-end mapping, DNase I footprinting, transient transfection reporter assays, cDNA cloning of MAZ\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (footprinting, cDNA cloning, functional overexpression assays) in a single rigorous study\",\n      \"pmids\": [\"8626793\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Methiothepin and spiperone act as inverse agonists at the 5-HT1A receptor, inhibiting both agonist-stimulated and basal [35S]GTPgammaS binding. Simulations using the extended ternary complex model indicate spiperone stabilizes receptor forms uncoupled from G proteins, while methiothepin may stabilize an inactive receptor form that retains G-protein coupling.\",\n      \"method\": \"[35S]GTPgammaS binding assay in CHO cells expressing human 5-HT1A receptor, GDP/sodium titration, extended ternary complex modeling\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro functional assay with mechanistic modeling and systematic pharmacological dissection\",\n      \"pmids\": [\"10617139\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Aripiprazole binds with high affinity to recombinant human 5-HT1A receptors and acts as a potent partial agonist, as demonstrated by stimulation of [35S]GTPgammaS binding that is fully blocked by a selective 5-HT1A antagonist.\",\n      \"method\": \"Radioligand binding and [35S]GTPgammaS functional assay in CHO cell membranes expressing human 5-HT1A receptor\",\n      \"journal\": \"European journal of pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — receptor binding plus functional G-protein activation assay with selective antagonist control\",\n      \"pmids\": [\"12063084\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The C(-1019)G polymorphism in the HTR1A promoter is associated with major depression and suicide. The C(-1019) allele forms a 26 bp palindrome that binds transcription factors NUDR/DEAF-1 and Hes5 to repress the 5-HT1A promoter; the G(-1019) allele abolishes NUDR-mediated repression. Stable NUDR expression in raphe cells reduced endogenous 5-HT1A protein and binding. NUDR co-localizes with 5-HT1A receptors in raphe cells and hippocampal/cortical neurons.\",\n      \"method\": \"EMSA, co-immunoprecipitation, stable cell line expression, radioligand binding, immunohistochemistry, case-control genetic association\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods establishing transcriptional mechanism in cell culture and in vivo; >500 citations\",\n      \"pmids\": [\"14507979\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Activation of 5-HT1A receptors in PFC pyramidal neurons inhibits NR2B subunit-containing NMDA receptor-mediated currents via a microtubule-dependent mechanism. The effect requires intact microtubule assembly, the kinesin motor KIF17 (which transports NR2B vesicles along dendrites), and CaMKII and MEK/ERK signaling. 5-HT1A activation reduces microtubule stability and decreases surface NR2B subunit density on dendrites.\",\n      \"method\": \"Whole-cell patch-clamp recordings in PFC slices, pharmacological inhibitors, siRNA knockdown of KIF17, immunocytochemistry, biochemical microtubule stability assay\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (electrophysiology, RNAi, biochemistry, imaging) in a single study defining a complete mechanistic pathway\",\n      \"pmids\": [\"15944377\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Cannabidiol (CBD) displaces [3H]8-OH-DPAT from the cloned human 5-HT1A receptor in a concentration-dependent manner and acts as a modest-affinity agonist, increasing [35S]GTPgammaS binding and decreasing cAMP levels similarly to serotonin.\",\n      \"method\": \"Radioligand displacement binding assay and [35S]GTPgammaS binding/cAMP assay in cells expressing human 5-HT1A receptor\",\n      \"journal\": \"Neurochemical research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — two independent functional assays in cell culture; single lab\",\n      \"pmids\": [\"16258853\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Native rat hippocampal 5-HT1A receptors exhibit constitutive G-protein (Galpha-o) activity in vitro; spiperone and methiothepin act as inverse agonists by reducing basal [35S]GTPgammaS binding to Galpha-o, and these effects are antagonized by WAY100,635 with affinities consistent with the 5-HT1A receptor.\",\n      \"method\": \"Anti-Galpha-o antibody capture coupled to scintillation proximity assay for [35S]GTPgammaS binding in native rat hippocampal membranes\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — native receptor preparation with selective pharmacological controls; single lab\",\n      \"pmids\": [\"17167032\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The C-terminal 17 aa domain of the 5-HT1A receptor interacts with Yif1B (a mammalian homologue of yeast Yif1p involved in ER-to-Golgi vesicular trafficking). This interaction was confirmed by GST pulldown from rat brain extracts and transfected cells. siRNA knockdown of Yif1B in primary neurons specifically prevented targeting of 5-HT1A receptor to distal dendrites without affecting other receptors.\",\n      \"method\": \"Yeast two-hybrid screen, GST pulldown, siRNA knockdown in primary neurons, immunofluorescence co-localization\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — yeast two-hybrid confirmed by GST pulldown from native tissue plus RNAi functional validation in primary neurons\",\n      \"pmids\": [\"18685031\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The 5-HT1A receptor forms homo-oligomers (predominantly dimers) at the plasma membrane of neuroblastoma cells. Agonist stimulation decreases apparent FRET efficiency between CFP/YFP-labeled receptor pairs, suggesting conformational rearrangement of oligomers rather than dissociation. Palmitoylation of the receptor is required for this agonist-induced conformational change, as acylation-deficient mutants fail to show the agonist-mediated FRET decrease.\",\n      \"method\": \"FRET (acceptor photobleaching, fluorescence lifetime, spectral analysis) in living N1E-115 cells; biochemical analysis with palmitoylation-deficient mutants\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple FRET approaches in living cells with mutagenesis; single lab\",\n      \"pmids\": [\"18381076\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Genetic disruption of RGS protein regulation at Galpha-i2 (G184S knock-in mice) selectively potentiates 5-HT1A receptor-mediated antidepressant-like and anxiolytic-like behaviors, and increases cortical/hippocampal GSK-3beta phosphorylation. Both behavioral and biochemical phenotypes are blocked by the 5-HT1A-selective antagonist WAY 100635, placing RGS-Galpha-i2 as a key negative regulator downstream of 5-HT1A receptor signaling.\",\n      \"method\": \"RGS-insensitive Galpha-i2 knock-in mice, behavioral tests, pharmacological blockade with WAY 100635, biochemical phosphorylation assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis in knock-in mice with pharmacological rescue and biochemical endpoint; multiple orthogonal methods\",\n      \"pmids\": [\"20534514\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Selective manipulation of 5-HT1A autoreceptor levels in raphe nuclei (without affecting postsynaptic heteroreceptors) causally determines raphe 5-HT neuron firing rates, stress resilience, and antidepressant response. 1A-High mice show blunted stress response and no antidepressant behavioral response; reducing autoreceptor levels prior to treatment converts non-responders to responders.\",\n      \"method\": \"Conditional transgenic mice with region-specific autoreceptor level manipulation, electrophysiology, behavioral tests, antidepressant treatment paradigm\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic causal manipulation with electrophysiological and behavioral readouts; strong preponderance of evidence\",\n      \"pmids\": [\"20152112\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Serotonin, acting via 5-HT1A receptors, hyperpolarizes orexin/hypocretin neurons through activation of GIRK channels (single-channel conductance ~33.8 pS). 5-HT1A receptor immunoreactivity was identified on orexin neurons, and WAY100635 blocked the hyperpolarization. Blockade of 5-HT1A receptors in orexin-neuron-intact (but not ablated) mice increased locomotor activity, indicating this pathway tonically inhibits orexin neuron activity.\",\n      \"method\": \"Patch-clamp recordings (whole-cell and single-channel) in hypothalamic slices from orexin-EGFP mice, pharmacology, immunohistochemistry, icv injection with orexin-ablated mouse comparison\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct electrophysiology with single-channel biophysics, immunohistochemistry, and in vivo pharmacogenetic validation\",\n      \"pmids\": [\"15306649\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"5-HT2A receptor activation in the hypothalamic paraventricular nucleus induces heterologous desensitization of co-expressed 5-HT1A receptors, as demonstrated by reduced oxytocin and ACTH responses to 5-HT1A agonist. Intra-PVN microinjection of a 5-HT2A antagonist dose-dependently prevented this desensitization. Double-label immunocytochemistry confirmed co-localization of 5-HT1A and 5-HT2A receptors in individual PVN neuroendocrine cells.\",\n      \"method\": \"In vivo neuroendocrine hormone assays, intra-PVN microinjections, double-label immunocytochemistry\",\n      \"journal\": \"The Journal of pharmacology and experimental therapeutics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo pharmacological interaction with microinjection controls and immunocytochemical colocalization; single lab\",\n      \"pmids\": [\"15064330\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"miR-26a-2 directly downregulates Htr1a expression in serotonergic neurons (confirmed by reporter assays with the Htr1a 5'UTR). In vivo, miR-26a-2 overexpression in serotonergic neurons improves stress resilience and antidepressant response, effects abrogated by Htr1a overexpression; miR-26a-2 knockdown increases anxiety and impairs antidepressant response, rescued by Htr1a silencing.\",\n      \"method\": \"Luciferase reporter assays, transgenic mouse models with serotonergic-neuron-specific miR-26a-2 overexpression or knockdown, behavioral tests, lentiviral Htr1a manipulation\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reporter assay for direct targeting plus reciprocal gain/loss-of-function in vivo with genetic rescue\",\n      \"pmids\": [\"30808545\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"HTR1A antagonism (WAY-100635) upregulates GnRH expression in GT1-7 neurons via an epigenetic mechanism: it reduces CBX4 expression, causing degradation of Polycomb Repressive Complex 1 (PRC1) and loss of H2AK119 ubiquitination at the GnRH promoter. CBX4 downregulation is mediated by suppression of PI3K/Akt and MAPK/ERK pathways.\",\n      \"method\": \"RNA-seq, ChIP-seq for CBX4 and H2AK119ub, co-immunoprecipitation, pharmacological inhibitor studies in GT1-7 cells\",\n      \"journal\": \"Molecular therapy. Nucleic acids\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal genomic and biochemical approaches; single lab, cell line model\",\n      \"pmids\": [\"34458005\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Cryo-EM structures of 5-HT1A receptor in complex with Gi protein were determined in apo state, bound to 5-HT, and bound to aripiprazole. Phosphatidylinositol 4-phosphate (PI4P) is present at the G-protein–5-HT1A interface and increases 5-HT1A-mediated G-protein activity. Cholesterol molecules directly shape the ligand-binding pocket and determine specificity for aripiprazole. Structured water molecules in the apo-receptor binding pocket mimic 5-HT to maintain basal activation.\",\n      \"method\": \"Cryo-EM structure determination, lipid biochemistry (PI4P functional assay), G-protein activation assay\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — cryo-EM structures with functional validation of lipid regulation; multiple structures with mechanistic insight\",\n      \"pmids\": [\"33762731\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Molecular dynamics simulations of the 5-HT1A receptor with two epimers of dihydrofuroaporphine (agonist vs. antagonist) revealed that the agonist mobilizes nearby amino acid residues as molecular switches to form a continuous water channel, whereas the antagonist epimer remains firmly stabilized in the binding pocket without triggering this conformational change.\",\n      \"method\": \"All-atom long-timescale molecular dynamics simulations with molecular interaction fingerprint analysis\",\n      \"journal\": \"Angewandte Chemie (International ed. in English)\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 — computational prediction only, no experimental mutagenesis validation\",\n      \"pmids\": [\"27244650\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"HTR1A interacts with TRIM21 and PSMD7 (components of the ubiquitin-proteasome pathway) to inhibit TβRII degradation, thereby suppressing TGF-β canonical and non-canonical signaling in triple-negative breast cancer cells. This was demonstrated by co-immunoprecipitation and RNA-seq analysis.\",\n      \"method\": \"Co-immunoprecipitation, siRNA screening, RNA-seq, in vivo xenograft experiments\",\n      \"journal\": \"Advanced science (Weinheim, Baden-Wurttemberg, Germany)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — co-immunoprecipitation plus in vivo functional experiments; single lab\",\n      \"pmids\": [\"35199941\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"A subpopulation (~16%) of serotonergic neurons in the dorsal, lateral, and median raphe does not express the somatodendritic 5-HT1A autoreceptor mRNA. These 5-HT1A-negative neurons fire more action potentials upon large depolarizing current injection than 5-HT1A-positive neurons, consistent with lack of autoinhibitory feedback from locally released 5-HT.\",\n      \"method\": \"Histochemistry in ePet1-eGFP and 5-HT1A-iCre/R26R mice, patch-clamp recording followed by single-cell PCR\",\n      \"journal\": \"ACS chemical neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — electrophysiology combined with single-cell PCR genotyping in identified neurons; single lab\",\n      \"pmids\": [\"23336048\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Genetic deletion of the 5-HT1A autoreceptor in knockout mice nearly doubles the mean firing rate of dorsal raphe 5-HT neurons. No compensatory changes in 5-HT1B, 5-HT1D, or alpha2-adrenergic autoreceptor function were detected in hippocampus or frontal cortex.\",\n      \"method\": \"Extracellular electrophysiological recordings in 5-HT1A knockout mice, radioligand release assays in preloaded brain slices\",\n      \"journal\": \"European journal of pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic loss-of-function with electrophysiology and neurochemical assays; clean KO model\",\n      \"pmids\": [\"11821026\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Glucocorticoid hormones negatively regulate transcription of the hippocampal 5-HT1A receptor gene: adrenalectomy increases 5-HT1A mRNA within 1 hour (preceding receptor binding site increases) and elevates transcription rate by 70% in nuclear run-on assays; dexamethasone treatment completely prevents this increase. Adrenalectomy did not alter functional coupling of 5-HT1A receptors to adenylyl cyclase or phospholipase C.\",\n      \"method\": \"In situ hybridization, RNase protection assays, nuclear run-on transcription assays, adrenalectomy/steroid replacement in rats\",\n      \"journal\": \"Brain research. Molecular brain research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — nuclear run-on plus mRNA quantification with pharmacological rescue; multiple orthogonal methods\",\n      \"pmids\": [\"7769998\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"HTR1A encodes a Gi/o-coupled GPCR that, upon serotonin binding, inhibits adenylyl cyclase and (at higher occupancy) activates phospholipase C via pertussis toxin-sensitive G proteins; it preferentially couples to Gi-alpha3 in raphe cells and Gi-alpha2 in hippocampal neurons, opening GIRK channels and closing calcium channels to hyperpolarize neurons; its dendritic targeting depends on interaction of its C-terminal domain with the ER/Golgi trafficking protein Yif1B; it forms palmitoylation-dependent homo-oligomers whose conformation changes upon agonist activation; cryo-EM structures reveal that phosphatidylinositol 4-phosphate at the G-protein interface enhances signaling, cholesterol shapes the ligand-binding pocket, and structured water molecules maintain basal activity; as a somatodendritic autoreceptor it provides inhibitory feedback that sets raphe neuron firing rate and serotonin release, and its expression is transcriptionally controlled by glucocorticoids, the MAZ/Sp1 promoter complex, and the NUDR/DEAF-1 repressor at the C(-1019)G polymorphism; RGS proteins acting at Galpha-i2 constrain 5-HT1A-mediated antidepressant signaling, and miR-26a-2 post-transcriptionally suppresses autoreceptor levels to modulate stress resilience.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"HTR1A encodes the serotonin 5-HT1A receptor, a Gi/Go-coupled GPCR that serves as both a somatodendritic autoreceptor on raphe serotonergic neurons and a postsynaptic receptor in limbic and cortical regions, functioning as a master regulator of serotonergic tone, stress resilience, and antidepressant responsiveness. Upon serotonin binding, the receptor inhibits adenylyl cyclase via pertussis toxin-sensitive G proteins (primarily Gαi2) and activates GIRK potassium channels to hyperpolarize target neurons; downstream signaling engages PI3K/Akt, MAPK/ERK, and CaMKII pathways that modulate NMDA receptor trafficking, GSK-3β phosphorylation, and chromatin remodeling [PMID:2549039, PMID:20534514, PMID:15944377, PMID:15306649, PMID:34458005]. The receptor forms palmitoylation-dependent homo-oligomers at the plasma membrane whose conformation is regulated by agonist binding, and its dendritic targeting requires interaction with the trafficking protein Yif1B [PMID:18381076, PMID:18685031]. Autoreceptor expression levels in the raphe, regulated transcriptionally by glucocorticoids and post-transcriptionally by miR-26a-2, causally determine raphe firing rate and behavioral outcomes including stress vulnerability and antidepressant efficacy [PMID:20152112, PMID:7769998, PMID:30808545].\",\n  \"teleology\": [\n    {\n      \"year\": 1989,\n      \"claim\": \"Establishing the fundamental signaling mechanism: the cloned human 5-HT1A receptor was shown to couple to Gi/Go proteins to inhibit adenylyl cyclase and, at higher concentrations, stimulate phospholipase C, defining the receptor as a dual-pathway Gi/Go-coupled GPCR.\",\n      \"evidence\": \"Stable expression of cloned human 5-HT1A in COS-7/HeLa cells with cAMP and inositol phosphate assays plus pertussis toxin sensitivity\",\n      \"pmids\": [\"2549039\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological relevance of PLC pathway at native expression levels unclear\", \"G protein subtype specificity not resolved\", \"No neuronal context\"]\n    },\n    {\n      \"year\": 1990,\n      \"claim\": \"Answering how autoreceptors control serotonin output: in vivo microdialysis demonstrated that 5-HT1A autoreceptors in the dorsal raphe tonically inhibit hippocampal 5-HT release, establishing the receptor's autoinhibitory function in intact circuits.\",\n      \"evidence\": \"In vivo microdialysis in anesthetized rats with 8-OH-DPAT and pindolol antagonism\",\n      \"pmids\": [\"2259248\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of signal transduction from soma to terminals not resolved\", \"Contribution of postsynaptic vs. presynaptic receptors not dissected\"]\n    },\n    {\n      \"year\": 1992,\n      \"claim\": \"Revealing the temporal dynamics of autoreceptor plasticity: chronic but not acute agonist exposure desensitizes 5-HT1A autoreceptors, providing a mechanistic basis for the delayed therapeutic onset of SSRIs.\",\n      \"evidence\": \"In vivo microdialysis in rats after 7-day 8-OH-DPAT treatment measuring attenuated striatal 5-HT suppression\",\n      \"pmids\": [\"1436390\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular mechanism of desensitization (internalization vs. uncoupling) not determined\", \"Whether desensitization occurs equivalently at postsynaptic receptors unknown\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Identifying transcriptional regulation: glucocorticoids were shown to repress 5-HT1A gene transcription in hippocampus, linking HPA axis activity to receptor density.\",\n      \"evidence\": \"Nuclear run-on transcription assays after adrenalectomy ± dexamethasone in rats\",\n      \"pmids\": [\"7769998\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether repression is via direct GRE binding or indirect mechanism not resolved\", \"Raphe vs. hippocampal regulation not compared\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Genetic proof that autoreceptors tonically inhibit raphe firing: 5-HT1A knockout mice showed nearly doubled dorsal raphe neuron firing rates without compensatory changes in 5-HT1B or α2-adrenergic function, confirming the non-redundant autoinhibitory role.\",\n      \"evidence\": \"Extracellular electrophysiology in 5-HT1A−/− mice with [3H]5-HT release assays\",\n      \"pmids\": [\"11821026\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Contribution of postsynaptic feedback loops not excluded\", \"Developmental compensation in constitutive knockout possible\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Defining the effector channel in intact neurons: 5-HT1A receptors hyperpolarize orexin neurons by activating GIRK channels with ~33.8 pS single-channel conductance, and cross-receptor desensitization by 5-HT2A activation was demonstrated in PVN neuroendocrine cells.\",\n      \"evidence\": \"Patch-clamp including single-channel recordings in orexin-EGFP mouse hypothalamic slices; intra-PVN microinjection with 5-HT2A antagonist MDL100907\",\n      \"pmids\": [\"15306649\", \"15064330\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"GIRK subunit composition at 5-HT1A-expressing neurons not identified\", \"Generalizability of heterologous desensitization across brain regions unclear\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Revealing a novel postsynaptic mechanism: 5-HT1A activation was shown to reduce NMDA receptor surface expression in PFC pyramidal neurons via CaMKII- and MEK/ERK-dependent regulation of KIF17-mediated dendritic trafficking of NR2B subunits.\",\n      \"evidence\": \"Whole-cell patch-clamp, KIF17 siRNA, CaMKII/MEK inhibitors, and surface NR2B immunocytochemistry in rat PFC neurons\",\n      \"pmids\": [\"15944377\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether this trafficking mechanism operates in vivo during antidepressant treatment unknown\", \"Direct phosphorylation targets linking Gi to CaMKII/ERK not identified\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Solving how the receptor reaches dendrites: Yif1B was identified as the trafficking partner that selectively targets 5-HT1A to distal dendrites via the receptor's C-terminal domain, and palmitoylation was shown to be required for agonist-induced conformational changes in receptor homo-oligomers.\",\n      \"evidence\": \"Yeast two-hybrid, GST pull-down, siRNA in primary neurons (Yif1B); FRET/FLIM with palmitoylation-site mutagenesis in neuroblastoma cells (oligomerization)\",\n      \"pmids\": [\"18685031\", \"18381076\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Yif1B interaction is required for autoreceptor vs. postsynaptic targeting not tested\", \"Functional consequence of oligomeric conformational change for signaling unknown\", \"Structure of the oligomeric interface not determined\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Establishing Gαi2 as the critical G protein for antidepressant-relevant signaling and proving that autoreceptor levels causally determine stress resilience and antidepressant response: RGS-insensitive Gαi2 knock-in mice showed enhanced GSK-3β phosphorylation blocked by WAY100635, while conditional autoreceptor level manipulation bidirectionally controlled raphe firing, behavioral despair, and fluoxetine responsiveness.\",\n      \"evidence\": \"Gαi2-G184S knock-in mice with forced swim test and phospho-GSK-3β Western blot; conditional transgenic mice with selective raphe 5-HT1A manipulation plus electrophysiology and behavioral testing\",\n      \"pmids\": [\"20534514\", \"20152112\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream targets of GSK-3β mediating behavioral phenotype not mapped\", \"Whether Gαi2 vs. Gαo preference differs between autoreceptor and heteroreceptor pools unknown\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identifying post-transcriptional control of autoreceptor levels: miR-26a-2 was shown to repress HTR1A expression in serotonergic neurons, with epistasis experiments demonstrating that miR-26a-2's effects on stress resilience and antidepressant response are mediated through HTR1A.\",\n      \"evidence\": \"Reporter assay with Htr1a 5'UTR; conditional transgenic gain/loss-of-function with genetic rescue; chronic social defeat in mice\",\n      \"pmids\": [\"30808545\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether miR-26a-2 regulation is specific to raphe or also affects postsynaptic HTR1A unknown\", \"Upstream signals controlling miR-26a-2 expression not identified\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Extending receptor function beyond neurons: HTR1A was found to stabilize TβRII by interacting with TRIM21 and PSMD7 to inhibit ubiquitin-proteasome degradation, suppressing TGF-β signaling in triple-negative breast cancer cells.\",\n      \"evidence\": \"Co-immunoprecipitation, RNA-seq, siRNA screen, and in vivo tumor experiments in breast cancer cells\",\n      \"pmids\": [\"35199941\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether this non-canonical protein-protein interaction mechanism operates independently of canonical Gi signaling unknown\", \"Relevance to normal physiology vs. cancer-specific context not established\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis for the 5-HT1A homo-oligomeric interface and its functional significance, the molecular mechanism by which autoreceptor desensitization occurs during chronic SSRI treatment, and how region-specific transcriptional and post-transcriptional regulation produces differential autoreceptor vs. heteroreceptor expression levels.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No high-resolution structure of the activated 5-HT1A–Gi complex published in the timeline\", \"Molecular basis of desensitization (phosphorylation, internalization, downregulation) not dissected\", \"Mechanism of region-specific promoter regulation by Deaf1/Hes factors at C(-1019)G polymorphism not experimentally validated in the timeline\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 8, 9]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [1, 18, 19]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 9, 5]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0162582\", \"supporting_discovery_ids\": [0, 3, 5]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [1, 4, 5, 21]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"GNAI2\",\n      \"GNAO1\",\n      \"YIF1B\",\n      \"TRIM21\",\n      \"PSMD7\",\n      \"KIF17\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"HTR1A encodes the 5-hydroxytryptamine receptor 1A, a Gi/o-coupled GPCR that inhibits adenylyl cyclase at nanomolar serotonin concentrations and activates phospholipase C at higher agonist occupancy, both via pertussis toxin-sensitive G proteins, with cell-type-dependent preferential coupling to Gαi2 or Gαi3 [PMID:2549039, PMID:8218170]. As a somatodendritic autoreceptor in raphe serotonergic neurons, it opens GIRK channels to hyperpolarize neurons and set firing rate; genetic deletion nearly doubles raphe firing rate, and selective manipulation of autoreceptor levels causally determines stress resilience and antidepressant responsiveness [PMID:11821026, PMID:20152112, PMID:15306649]. Cryo-EM structures reveal that phosphatidylinositol 4-phosphate at the receptor–Gi interface enhances signaling, cholesterol directly shapes the ligand-binding pocket, and structured water molecules in the apo state maintain constitutive activity [PMID:33762731]. Transcription is driven by the MAZ/Sp1 promoter complex and repressed by NUDR/DEAF-1 at the C(-1019)G polymorphism—a variant associated with major depression and suicide—while glucocorticoids negatively regulate hippocampal HTR1A transcription and miR-26a-2 post-transcriptionally suppresses autoreceptor levels [PMID:8626793, PMID:14507979, PMID:7769998, PMID:30808545].\",\n  \"teleology\": [\n    {\n      \"year\": 1987,\n      \"claim\": \"Cloning of the HTR1A gene revealed an intronless GPCR with adrenergic receptor homology, establishing the molecular identity of the 5-HT1A receptor for the first time.\",\n      \"evidence\": \"Molecular cloning via cross-hybridization with β2-adrenergic receptor probe, DNA sequencing\",\n      \"pmids\": [\"3041227\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No functional data confirming receptor activity\", \"Endogenous ligand binding not demonstrated\"]\n    },\n    {\n      \"year\": 1988,\n      \"claim\": \"Functional expression of the cloned gene confirmed that it encodes a receptor with the full pharmacological profile of the native 5-HT1A site, validating the clone's identity.\",\n      \"evidence\": \"Transient expression in COS-7 cells with radioligand binding assays\",\n      \"pmids\": [\"3138543\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream signaling pathways not yet characterized\", \"G-protein coupling specificity unknown\"]\n    },\n    {\n      \"year\": 1989,\n      \"claim\": \"Reconstitution of signaling showed the receptor inhibits adenylyl cyclase and, at higher occupancy, activates phospholipase C—both through pertussis toxin-sensitive G proteins—defining its dual effector coupling.\",\n      \"evidence\": \"cAMP and inositol phosphate assays in COS-7 and HeLa cells with pertussis toxin treatment\",\n      \"pmids\": [\"2549039\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of specific Gα subunits unknown\", \"In vivo effector pathway relevance not established\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Identification of cell-type-dependent coupling to specific Gαi subunits (Gαi2 vs. Gαi3) explained how the same receptor could produce different signaling outputs in different neuronal populations.\",\n      \"evidence\": \"Co-immunoprecipitation with Gi-subtype-specific antisera and adenylyl cyclase inhibition in HeLa and CHO-K1 cells\",\n      \"pmids\": [\"8218170\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Native neuronal Gα coupling preferences not determined\", \"Mechanism of cell-type selectivity unclear\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Demonstrating that glucocorticoids negatively regulate HTR1A transcription at the nuclear run-on level revealed a mechanism by which stress hormones modulate serotonergic tone.\",\n      \"evidence\": \"Nuclear run-on assays, in situ hybridization, adrenalectomy/dexamethasone replacement in rats\",\n      \"pmids\": [\"7769998\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Glucocorticoid response element not mapped\", \"Whether regulation is direct or indirect not resolved\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Characterization of the TATA-less, GC-rich promoter and identification of MAZ and Sp1 as transcriptional activators defined the basal transcriptional machinery for HTR1A expression.\",\n      \"evidence\": \"DNase I footprinting, reporter assays, MAZ cDNA cloning\",\n      \"pmids\": [\"8626793\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cell-type-specific transcriptional regulation not addressed\", \"Relationship to in vivo autoreceptor vs. heteroreceptor expression unknown\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Demonstration that methiothepin and spiperone act as inverse agonists established that 5-HT1A receptors possess constitutive activity, with distinct mechanisms of inverse agonism (G-protein-uncoupled vs. inactive coupled state).\",\n      \"evidence\": \"[35S]GTPγS binding in CHO cells with extended ternary complex modeling\",\n      \"pmids\": [\"10617139\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Constitutive activity not yet confirmed in native tissue at that time\", \"Structural basis of basal activity unknown\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Genetic deletion of 5-HT1A in knockout mice nearly doubled raphe firing rate without compensatory changes in other autoreceptors, providing causal evidence that the autoreceptor is the principal brake on serotonergic neuron activity.\",\n      \"evidence\": \"Extracellular recordings in dorsal raphe of 5-HT1A KO mice, radioligand release assays\",\n      \"pmids\": [\"11821026\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Postsynaptic heteroreceptor contributions confounded in global KO\", \"Developmental compensation cannot be excluded\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Discovery that the C(-1019)G promoter polymorphism abolishes NUDR/DEAF-1-mediated repression linked a specific transcriptional mechanism to major depression risk, connecting autoreceptor expression levels to psychiatric disease.\",\n      \"evidence\": \"EMSA, co-IP, stable expression reducing endogenous 5-HT1A, immunohistochemistry, case-control genetic association\",\n      \"pmids\": [\"14507979\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Causal chain from polymorphism to disease phenotype not fully established\", \"Population-level effect size and replication across cohorts debated\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Electrophysiological recordings showed that 5-HT1A activation hyperpolarizes orexin neurons via GIRK channels (~33.8 pS), providing a defined ionic mechanism for serotonergic inhibition of arousal circuits.\",\n      \"evidence\": \"Whole-cell and single-channel patch clamp in hypothalamic slices, pharmacological blockade, in vivo validation with orexin-ablated mice\",\n      \"pmids\": [\"15306649\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Contribution to sleep-wake regulation in intact circuitry not quantified\", \"Whether GIRK subunit composition differs across 5-HT1A-expressing cell types unresolved\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Demonstration that 5-HT1A activation inhibits NMDA-NR2B currents in PFC via microtubule destabilization and KIF17-dependent trafficking revealed a non-canonical effector pathway linking serotonin to glutamatergic synaptic plasticity.\",\n      \"evidence\": \"Patch-clamp in PFC slices, KIF17 siRNA, microtubule stability assays, immunocytochemistry\",\n      \"pmids\": [\"15944377\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether this pathway operates at autoreceptors or only heteroreceptors not tested\", \"In vivo relevance to cognitive function not established\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identification of Yif1B as a C-terminal interactor required for dendritic targeting of 5-HT1A established a specific ER/Golgi trafficking mechanism for somatodendritic receptor localization.\",\n      \"evidence\": \"Yeast two-hybrid, GST pulldown from rat brain, siRNA in primary neurons\",\n      \"pmids\": [\"18685031\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Yif1B loss affects autoreceptor function in vivo untested\", \"Other trafficking partners not explored\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"FRET-based detection of palmitoylation-dependent homo-oligomers whose conformation changes upon agonist activation revealed that 5-HT1A functions as a dynamic oligomeric complex at the plasma membrane.\",\n      \"evidence\": \"Multiple FRET techniques in living N1E-115 cells with palmitoylation-deficient mutants\",\n      \"pmids\": [\"18381076\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Oligomeric stoichiometry and interface not structurally resolved\", \"Functional significance of oligomerization for signaling not determined\", \"Confirmed in only one cell line\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Region-specific autoreceptor manipulation causally demonstrated that raphe 5-HT1A autoreceptor levels determine stress resilience and antidepressant response, separating autoreceptor from heteroreceptor functions in vivo.\",\n      \"evidence\": \"Conditional transgenic mice with raphe-specific autoreceptor level manipulation, electrophysiology, behavioral paradigms\",\n      \"pmids\": [\"20152112\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism downstream of autoreceptor level changes not detailed\", \"Translational relevance to human pharmacotherapy not directly tested\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Genetic disruption of RGS regulation at Gαi2 selectively potentiated 5-HT1A-mediated antidepressant-like behavior, identifying RGS-Gαi2 as a key negative regulator constraining the receptor's therapeutic signaling axis.\",\n      \"evidence\": \"RGS-insensitive Gαi2 knock-in mice, WAY-100635 blockade, GSK-3β phosphorylation assays\",\n      \"pmids\": [\"20534514\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which specific RGS family member(s) are responsible not identified\", \"Whether RGS regulation differs between auto- and heteroreceptors unknown\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identification of miR-26a-2 as a direct post-transcriptional repressor of HTR1A in serotonergic neurons added a microRNA-based regulatory layer to autoreceptor expression control, with bidirectional effects on stress resilience.\",\n      \"evidence\": \"Luciferase reporter assays with Htr1a 5'UTR, serotonergic-neuron-specific transgenic gain/loss-of-function mice, reciprocal genetic rescue\",\n      \"pmids\": [\"30808545\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Endogenous miR-26a-2 levels in human raphe neurons not measured\", \"Interaction with other post-transcriptional regulators not explored\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Cryo-EM structures of 5-HT1A–Gi complexes resolved longstanding questions about how lipids regulate receptor function: PI4P at the G-protein interface enhances signaling, cholesterol shapes ligand selectivity, and structured waters maintain basal activity.\",\n      \"evidence\": \"Cryo-EM structure determination (apo, 5-HT-bound, aripiprazole-bound), PI4P functional assays, G-protein activation assays\",\n      \"pmids\": [\"33762731\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structures determined in detergent/lipid nanodisc — native membrane environment effects not captured\", \"Dynamic transitions between active and inactive states not resolved\", \"Oligomeric state not visible in structures\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis for cell-type-specific Gαi subtype selectivity, the identity of RGS proteins that constrain 5-HT1A signaling in vivo, and whether the oligomeric state observed by FRET is functionally relevant in native neurons.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structure of autoreceptor vs. heteroreceptor conformational differences\", \"RGS family member identity at 5-HT1A not determined\", \"In vivo functional consequence of oligomerization unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [1, 2, 5, 6, 9, 10, 19]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [2, 8, 14, 15]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [1, 12, 15, 19]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [11]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 3, 5, 10, 13, 19]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [8, 14, 15, 22, 23]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [4, 7, 24]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"GNAI2\",\n      \"GNAI3\",\n      \"GNAO1\",\n      \"YIF1B\",\n      \"MAZ\",\n      \"DEAF1\",\n      \"TRIM21\",\n      \"PSMD7\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}